_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
725540222,5/25/2015 16:17:39,1643047560,5/25/2015 16:17:22,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[CONTRAINDICATES] [SIDE_EFFECT] [NONE],"[CONTRAINDICATES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:19:29,1643048037,5/25/2015 16:19:05,false,elite,1,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],persistent,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:27:55,1643049899,5/25/2015 16:27:45,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],persistent,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:36:25,1643051515,5/25/2015 16:35:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:38:41,1643052123,5/25/2015 16:38:08,false,prodege,1,22031444,GBR,M4,Southampton,2.98.199.6,[IS_A],[IS_A],HEADACHE commonly can become TENSION TYPE HEADACHE,N/a,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:38:53,1643052201,5/25/2015 16:37:57,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [IS_A],"[LOCATION]
[IS_A]","Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",n/a,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:39:20,1643052312,5/25/2015 16:38:29,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[MANIFESTATION],[MANIFESTATION],can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:41:52,1643052989,5/25/2015 16:41:36,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[NONE]",N/A,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:46:54,1643054162,5/25/2015 16:45:40,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CAUSES],[CAUSES],commonly can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:51:32,1643055429,5/25/2015 16:50:49,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[IS_A],[IS_A],HEADACHE commonly can become TENSION TYPE HEADACHE,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:59:08,1643057779,5/25/2015 16:57:48,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 16:59:22,1643057887,5/25/2015 16:58:51,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION] [OTHER] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]
[OTHER]",can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 17:02:39,1643059248,5/25/2015 17:01:47,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[MANIFESTATION],[MANIFESTATION],can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 17:05:06,1643060308,5/25/2015 17:03:57,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[IS_A],[IS_A],can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540222,5/25/2015 17:05:34,1643060491,5/25/2015 17:04:53,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[IS_A],[IS_A],commonly can become,N/A,102,131,1,109,152,TWrex-cause,812902-FS1,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE
725540223,5/25/2015 15:50:18,1643041034,5/25/2015 15:50:04,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[ASSOCIATED_WITH] [PART_OF] [NONE],"[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 15:53:04,1643041757,5/25/2015 15:52:49,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],previously,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 15:54:16,1643041969,5/25/2015 15:54:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],IMMUNE THROMBOCYTOPENIC PURPURA,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 15:55:00,1643042126,5/25/2015 15:54:32,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[IS_A],[IS_A],was known as,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 15:55:10,1643042154,5/25/2015 15:54:47,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[OTHER],[OTHER],previously known as,n/a,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 15:57:29,1643042614,5/25/2015 15:57:04,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[OTHER],[OTHER],PRIMARY IMMUNE THROMBOCYTOPENIA previously known as IMMUNE THROMBOCYTOPENIC PURPURA,NONE,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:05:43,1643044285,5/25/2015 16:04:34,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[OTHER],[OTHER],PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as IMMUNE THROMBOCYTOPENIC PURPURA,n/a,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:06:06,1643044373,5/25/2015 16:04:49,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[OTHER],[OTHER],previously known as,n/a,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:07:35,1643044727,5/25/2015 16:07:22,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[MANIFESTATION],[MANIFESTATION],idiopathic,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:07:59,1643044796,5/25/2015 16:07:46,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[LOCATION] [SIDE_EFFECT] [OTHER] [NONE],"[LOCATION]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:09:05,1643045048,5/25/2015 16:08:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[OTHER],[OTHER],was previously known as,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:12:51,1643046170,5/25/2015 16:11:57,false,clixsense,1.0,30544555,USA,TX,Mount Pleasant,70.196.7.174,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",PRIMARY IMMUNE THROMBOCYTOPENIA previously known as IMMUNE THROMBOCYTOPENIC PURPURA,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:13:41,1643046490,5/25/2015 16:13:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],known as,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:13:42,1643046492,5/25/2015 16:12:34,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER] [IS_A],"[IS_A]
[OTHER]",PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,n/a,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540223,5/25/2015 16:13:49,1643046521,5/25/2015 16:12:33,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],PRIMARY IMMUNE THROMBOCYTOPENIA was known as IMMUNE THROMBOCYTOPENIC PURPURA,N/A,12,82,1,42,113,TWrex-cause,814131-FS1,Comments: • PRIMARY IMMUNE THROMBOCYTOPENIA was previously known as idiopathic or IMMUNE THROMBOCYTOPENIC PURPURA,PRIMARY IMMUNE THROMBOCYTOPENIA,IMMUNE THROMBOCYTOPENIC PURPURA
725540224,5/25/2015 15:55:11,1643042174,5/25/2015 15:54:59,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 15:57:35,1643042629,5/25/2015 15:57:23,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]
[NONE]",N/A,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 15:59:16,1643043028,5/25/2015 15:58:56,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],OSTEOARTICULAR SPOROTRICHOSIS:,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:01:57,1643043587,5/25/2015 16:01:34,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],429 AMPHOTERICIN B OSTEOARTICULAR SPOROTRICHOSIS:,NONE,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:10:03,1643045290,5/25/2015 16:09:37,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatment,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:11:01,1643045559,5/25/2015 16:10:38,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],AMPHOTERICIN B in patients with OSTEOARTICULAR SPOROTRICHOSIS:,n/a,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:12:22,1643046018,5/25/2015 16:12:05,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[NONE] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:13:23,1643046391,5/25/2015 16:12:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in patients with treatment,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:16:03,1643047071,5/25/2015 16:15:50,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:20:13,1643048167,5/25/2015 16:19:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment duration,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:22:06,1643048590,5/25/2015 16:21:06,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],AMPHOTERICIN B in patients with OSTEOARTICULAR SPOROTRICHOSIS: for a treatment,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:22:44,1643048724,5/25/2015 16:21:30,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",n/a,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:24:09,1643049099,5/25/2015 16:22:59,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],in patients with 5 mg/kg daily,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:24:20,1643049129,5/25/2015 16:24:07,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540224,5/25/2015 16:26:42,1643049647,5/25/2015 16:24:09,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],response,N/A,59,5,-1,87,19,TWrex-cause,804299-FS1,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B
725540225,5/25/2015 15:54:56,1643042085,5/25/2015 15:54:39,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CONTRAINDICATES],[CONTRAINDICATES],alterations,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 15:57:21,1643042583,5/25/2015 15:56:56,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",N/A,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 15:58:39,1643042876,5/25/2015 15:58:23,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],used for postoperative,n/a,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 15:58:55,1643042910,5/25/2015 15:58:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CHRONIC PAIN,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:01:31,1643043504,5/25/2015 16:01:05,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],MEPERIDINE used for postoperative CHRONIC PAIN,NONE,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:09:35,1643045198,5/25/2015 16:09:21,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],"myoclonus,",N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:10:37,1643045431,5/25/2015 16:10:02,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CONTRAINDICATES],[CONTRAINDICATES],MEPERIDINE used for CHRONIC PAIN found neuroexcitatory effects,n/a,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:12:03,1643045962,5/25/2015 16:11:44,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[MANIFESTATION] [IS_A] [OTHER] [NONE],"[MANIFESTATION]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:12:32,1643046064,5/25/2015 16:11:50,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],used for,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:15:49,1643047009,5/25/2015 16:15:37,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[LOCATION],[LOCATION],without,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:19:21,1643048013,5/25/2015 16:18:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],used for,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:21:05,1643048409,5/25/2015 16:19:23,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],MEPERIDINE used for CHRONIC PAIN,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:21:28,1643048503,5/25/2015 16:20:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],"MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",n/a,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:22:57,1643048784,5/25/2015 16:21:29,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],used for,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540225,5/25/2015 16:23:49,1643048999,5/25/2015 16:23:12,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],alterations,N/A,50,13,-1,61,23,TWrex-cause,800890-FS1,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE
725540226,5/25/2015 15:43:41,1643039040,5/25/2015 15:43:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],hemolysis,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:46:32,1643039919,5/25/2015 15:46:15,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],"autoantibodies, MONONUCLEOSIS malaria",N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:46:58,1643040039,5/25/2015 15:46:46,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[NONE]",N/A,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:47:23,1643040227,5/25/2015 15:47:12,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],SPLENOMEGALY,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:48:04,1643040411,5/25/2015 15:47:46,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],appropriate,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:48:39,1643040593,5/25/2015 15:47:51,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"infections induce erythrocyte autoantibodies, MONONUCLEOSIS Fever, SPLENOMEGALY",NONE,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:48:43,1643040602,5/25/2015 15:47:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"autoantibodies, such as",n/a,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:48:52,1643040626,5/25/2015 15:47:58,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[NONE],[NONE],n/a,there is no explicit relation stated between the two terms,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:48:57,1643040641,5/25/2015 15:48:06,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",can induce suggest in,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:49:39,1643040838,5/25/2015 15:48:17,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:49:48,1643040873,5/25/2015 15:48:13,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"as far as I can tell, they are not related, the two sentences have no realtion between the two words i can find",146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:56:08,1643042303,5/25/2015 15:54:46,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],suggest,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:58:03,1643042738,5/25/2015 15:57:25,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CONTRAINDICATES] [SYMPTOM],"[SYMPTOM]
[CONTRAINDICATES]","such as mycoplasma MONONUCLEOSIS Fever, SPLENOMEGALY and hemolysis suggest malaria",n/a,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 15:59:49,1643043191,5/25/2015 15:59:07,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient",n/a,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540226,5/25/2015 16:03:26,1643043887,5/25/2015 16:02:14,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MONONUCLEOSIS information immune hemolytic SPLENOMEGALY,N/A,146,78,1,157,91,TWrex-cause,813567-FS1,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS
725540227,5/25/2015 16:21:27,1643048507,5/25/2015 16:21:15,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[PREVENTS],[PREVENTS],prevent,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 16:29:47,1643050266,5/25/2015 16:29:33,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],prevent,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 16:45:44,1643053893,5/25/2015 16:45:01,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[PART_OF] [OTHER] [NONE],"[PART_OF]
[OTHER]
[NONE]",N/A,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 16:54:38,1643056301,5/25/2015 16:53:10,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],GENITAL HPV INFECTION EXTERNAL GENITAL WARTS,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:04:09,1643059897,5/25/2015 17:03:37,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS] [OTHER],"[PREVENTS]
[OTHER]",or,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:09:08,1643062301,5/25/2015 17:07:56,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:09:12,1643062387,5/25/2015 17:08:07,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],HPV INFECTION,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:09:28,1643062475,5/25/2015 17:08:46,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Relation not expressed by terms above.,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:09:37,1643062535,5/25/2015 17:09:09,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [SYMPTOM] [MANIFESTATION] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]
[MANIFESTATION]
[NONE]",N/A,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:10:00,1643062715,5/25/2015 17:09:25,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[NONE],[NONE],N/A,they are seperate conditions just listed together,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:18:03,1643066619,5/25/2015 17:16:34,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],prevent,n/a,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:19:19,1643067189,5/25/2015 17:18:04,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[OTHER],[OTHER],prevent,n/a,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:22:19,1643068540,5/25/2015 17:21:20,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS,n/a,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:22:54,1643068839,5/25/2015 17:22:19,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[TREATS] [SYMPTOM] [IS_A] [PART_OF] [NONE],"[TREATS]
[SYMPTOM]
[IS_A]
[PART_OF]
[NONE]",N/A,N/A,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540227,5/25/2015 17:32:43,1643073246,5/25/2015 17:30:26,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[ASSOCIATED_WITH],[ASSOCIATED_WITH],condoms prevent,n/a,69,47,1,90,68,TWrex-cause,811269-FS1,"1]  Manhart LE, Koutsky LA. Do condoms prevent GENITAL HPV INFECTION EXTERNAL GENITAL WARTS or cervical neoplasia.",EXTERNAL GENITAL WARTS,GENITAL HPV INFECTION
725540228,5/25/2015 15:49:47,1643040869,5/25/2015 15:49:35,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [MANIFESTATION] [ASSOCIATED_WITH] [NONE],"[TREATS]
[MANIFESTATION]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 15:52:28,1643041630,5/25/2015 15:52:16,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 15:52:48,1643041706,5/25/2015 15:52:19,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PULMONARY EMBOLISM,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 15:54:09,1643041948,5/25/2015 15:53:47,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],compared with treatment,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 15:54:30,1643042019,5/25/2015 15:54:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 15:54:35,1643042027,5/25/2015 15:54:04,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],initial treatment,n/a,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 15:56:46,1643042459,5/25/2015 15:56:16,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],HEPARIN initial treatment of PULMONARY EMBOLISM,NONE,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:02:40,1643043705,5/25/2015 16:02:19,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment of,n/a,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:03:54,1643044034,5/25/2015 16:03:38,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],HEPARIN for the initial treatment of PULMONARY EMBOLISM,n/a,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:07:03,1643044547,5/25/2015 16:06:50,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatment,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:07:30,1643044702,5/25/2015 16:07:15,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[ASSOCIATED_WITH] [OTHER] [NONE],"[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:08:08,1643044835,5/25/2015 16:07:31,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the initial treatment of,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:10:48,1643045495,5/25/2015 16:10:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM,n/a,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:11:51,1643045922,5/25/2015 16:10:56,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],HEPARIN for treatment of PULMONARY EMBOLISM,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540228,5/25/2015 16:11:54,1643045953,5/25/2015 16:10:15,false,clixsense,1.0,30544555,USA,TX,Mount Pleasant,70.196.7.174,[TREATS],[TREATS],HEPARIN treatment of PULMONARY EMBOLISM,N/A,100,63,-1,117,70,TWrex-cause,803804-FS1,"Wan S, Quinlan DJ, Agnelli G et al. Thrombolysis compared with HEPARIN for the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,HEPARIN
725540229,5/25/2015 17:16:03,1643065614,5/25/2015 17:14:57,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[PREVENTS] [CONTRAINDICATES] [PART_OF] [NONE],"[PREVENTS]
[CONTRAINDICATES]
[PART_OF]
[NONE]",N/A,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:16:27,1643065776,5/25/2015 17:15:58,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",presents as,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:16:36,1643065825,5/25/2015 17:16:13,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[SYMPTOM],[SYMPTOM],presents as,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:18:28,1643066790,5/25/2015 17:17:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],presents as,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:31:38,1643072884,5/25/2015 17:31:00,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:39:22,1643076933,5/25/2015 17:38:46,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SYMPTOM],[SYMPTOM],presents,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:41:59,1643078350,5/25/2015 17:41:40,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION],[MANIFESTATION],presents as,n/a,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:43:53,1643079344,5/25/2015 17:41:37,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[ASSOCIATED_WITH],[ASSOCIATED_WITH],typically presents,n/a,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:44:31,1643079732,5/25/2015 17:43:22,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]","HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",n/a,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:50:32,1643083259,5/25/2015 17:50:03,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,[MANIFESTATION],[MANIFESTATION],presents as,n/a,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 17:50:41,1643083321,5/25/2015 17:49:57,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],typically presents as SPLENOMEGALY,n/a,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 18:09:24,1643094005,5/25/2015 18:08:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],presents as,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 18:09:52,1643094313,5/25/2015 18:09:26,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[CAUSES],[CAUSES],typically presents as,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 18:10:43,1643094927,5/25/2015 18:10:08,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],infection.,n/a,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540229,5/25/2015 18:11:51,1643095694,5/25/2015 18:10:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],presents as,N/A,57,17,1,68,20,TWrex-cause,812638-FS1,"68   Clinically, HCL typically presents as pancytopenia, SPLENOMEGALY and opportunistic infection.",SPLENOMEGALY,HCL
725540230,5/25/2015 15:19:56,1643031649,5/25/2015 15:19:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],insidious onset,n/a,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:24:35,1643033070,5/25/2015 15:23:54,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],onset of NONPRODUCTIVE COUGH and characterizes IPF,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:27:04,1643033809,5/25/2015 15:26:51,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],characterizes,n/a,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:30:29,1643034843,5/25/2015 15:30:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],NONPRODUCTIVE COUGH characterizes IPF,na,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:30:35,1643034874,5/25/2015 15:30:20,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CONTRAINDICATES],[CONTRAINDICATES],dyspnea,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:33:24,1643035754,5/25/2015 15:32:51,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],NONPRODUCTIVE COUGH and dyspnea characterizes IPF,n/a,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:34:49,1643036158,5/25/2015 15:34:27,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:34:53,1643036210,5/25/2015 15:34:41,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[MANIFESTATION] [ASSOCIATED_WITH] [SIDE_EFFECT] [NONE],"[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:35:11,1643036308,5/25/2015 15:34:37,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[SYMPTOM],[SYMPTOM],insidious onset of,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:37:55,1643037042,5/25/2015 15:36:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],characterizes,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:38:07,1643037119,5/25/2015 15:37:39,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],and,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:39:12,1643037426,5/25/2015 15:38:56,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],examination,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:40:16,1643037743,5/25/2015 15:40:02,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[MANIFESTATION],[MANIFESTATION],examination NONPRODUCTIVE COUGH and,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:41:39,1643038283,5/25/2015 15:41:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],NONPRODUCTIVE COUGH,N/A,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540230,5/25/2015 15:42:05,1643038451,5/25/2015 15:41:05,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[MANIFESTATION],[MANIFESTATION],characterizes,n/a,77,123,1,95,126,TWrex-cause,812914-FS1,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF
725540231,5/25/2015 16:19:44,1643048080,5/25/2015 16:19:30,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[PREVENTS],[PREVENTS],prevention,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:28:10,1643050007,5/25/2015 16:27:57,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],prevention,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:36:38,1643051555,5/25/2015 16:36:26,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention of,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:39:04,1643052247,5/25/2015 16:38:42,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PREVENTS],[PREVENTS],in the prevention of,N/a,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:39:49,1643052428,5/25/2015 16:38:54,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.,n/a,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:40:00,1643052454,5/25/2015 16:39:22,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],prevention,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:43:04,1643053268,5/25/2015 16:41:54,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]
[NONE]",N/A,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:47:30,1643054261,5/25/2015 16:46:58,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[PREVENTS],[PREVENTS],prevention,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 16:52:14,1643055597,5/25/2015 16:51:55,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PREVENTS],[PREVENTS],FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 17:00:22,1643058232,5/25/2015 16:59:55,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],prevention of,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 17:00:46,1643058388,5/25/2015 16:59:24,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],prevention of,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 17:03:33,1643059585,5/25/2015 17:02:40,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[PREVENTS],[PREVENTS],prevention,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 17:05:38,1643060552,5/25/2015 17:05:07,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS],[PREVENTS],in the prevention of,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 17:06:09,1643060778,5/25/2015 17:05:48,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CAUSES] [SIDE_EFFECT] [NONE],"[CAUSES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540231,5/25/2015 17:06:09,1643060784,5/25/2015 17:05:35,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[PREVENTS],[PREVENTS],in the prevention of,N/A,151,98,-1,170,129,TWrex-cause,805151-FS1,"1]  Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, et al. Adjusted versus FIXED DOSE SUBCUTANEOUS HEPARIN in the prevention of DEEP VEIN THROMBOSIS after total hip replacement.",DEEP VEIN THROMBOSIS,FIXED DOSE SUBCUTANEOUS HEPARIN
725540232,5/25/2015 16:17:20,1643047416,5/25/2015 16:17:07,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[NONE]",N/A,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:19:03,1643047954,5/25/2015 16:18:48,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:27:42,1643049794,5/25/2015 16:27:26,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:34:58,1643051153,5/25/2015 16:32:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment with,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:37:56,1643051925,5/25/2015 16:35:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"ADDITIONAL RESOURCES Article Alimentary Pharmacology &amp; Therapeutics Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",n/a,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:38:06,1643051938,5/25/2015 16:37:35,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS] [LOCATION],"[TREATS]
[LOCATION]",treatment with,N/a,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:38:27,1643052080,5/25/2015 16:37:04,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],treatment with for,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:41:34,1643052881,5/25/2015 16:41:22,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[LOCATION] [ASSOCIATED_WITH] [OTHER] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:45:32,1643053876,5/25/2015 16:43:44,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],treatment,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:50:47,1643055219,5/25/2015 16:50:28,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],combination treatment with COLCHICINE for PRIMARY BILIARY CIRRHOSIS:,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:58:48,1643057642,5/25/2015 16:58:26,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment with,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 16:59:53,1643058037,5/25/2015 16:59:09,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment with,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 17:01:45,1643058853,5/25/2015 17:00:23,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],treatment,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 17:03:56,1643059738,5/25/2015 17:01:58,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No direct relation.,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540232,5/25/2015 17:05:44,1643060615,5/25/2015 17:04:34,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CAUSES] [SIDE_EFFECT] [NONE],"[CAUSES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,325,107,-1,349,117,TWrex-cause,800140-FS1,"ADDITIONAL RESOURCES  Article  Alimentary Pharmacology & Therapeutics  Ten year combination treatment with COLCHICINE and ursodeoxycholic acid for primary biliary cirrhosis: a double blind, placebo controlled trial on symptomatic patients  American Journal of Gastroenterology  Incomplete response to ursodeoxycholic acid in PRIMARY BILIARY CIRRHOSIS: is a double dosage worthwhile.",PRIMARY BILIARY CIRRHOSIS,COLCHICINE
725540233,5/25/2015 15:19:11,1643031517,5/25/2015 15:18:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],statement,n/a,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:22:45,1643032538,5/25/2015 15:21:36,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,Its a statement from the Consensus Group on Depression and ANXIETY,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:26:32,1643033639,5/25/2015 15:26:07,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:29:28,1643034491,5/25/2015 15:28:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],POSTTRAUMATIC STRESS DISORDER from Group on ANXIETY,na,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:30:03,1643034708,5/25/2015 15:29:50,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],statement,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:32:23,1643035448,5/25/2015 15:32:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on ANXIETY,n/a,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:32:55,1643035607,5/25/2015 15:31:56,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",Consensus statement on,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:34:03,1643035909,5/25/2015 15:33:32,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:34:20,1643036000,5/25/2015 15:34:06,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[TREATS] [LOCATION] [CONTRAINDICATES] [NONE],"[TREATS]
[LOCATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:35:43,1643036476,5/25/2015 15:34:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Consensus statement on,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:37:01,1643036822,5/25/2015 15:36:35,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],Consensus,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:38:37,1643037279,5/25/2015 15:38:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],statement,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:39:42,1643037575,5/25/2015 15:39:28,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SIDE_EFFECT],[SIDE_EFFECT],"Foa RC, al. Consensus statement POSTTRAUMATIC STRESS",N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:40:50,1643037937,5/25/2015 15:40:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Depression and ANXIETY,n/a,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540233,5/25/2015 15:41:09,1643038048,5/25/2015 15:40:25,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],statement on,N/A,190,103,1,196,132,TWrex-cause,814420-FS1,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER
725540234,5/25/2015 15:48:39,1643040596,5/25/2015 15:48:10,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PREVENTS] [MANIFESTATION] [NONE],"[PREVENTS]
[MANIFESTATION]
[NONE]",N/A,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:49:47,1643040866,5/25/2015 15:49:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],somatostatin,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:49:53,1643040906,5/25/2015 15:49:33,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treating,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:52:07,1643041496,5/25/2015 15:51:41,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],is used in treating,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:52:39,1643041670,5/25/2015 15:50:53,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],OCTREOTIDE ACETATE used in treating ACROMEGALY,NONE,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:52:41,1643041689,5/25/2015 15:52:27,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],used in treating,n/a,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:52:45,1643041698,5/25/2015 15:52:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],used in treating,n/a,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 15:56:36,1643042418,5/25/2015 15:55:55,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],is used in treating,n/a,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:01:27,1643043499,5/25/2015 16:01:05,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],OCTREOTIDE ACETATE is used in treating ACROMEGALY,n/a,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:05:41,1643044279,5/25/2015 16:05:02,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],synthetic,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:05:50,1643044336,5/25/2015 16:05:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],is used in treating,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:06:29,1643044450,5/25/2015 16:06:07,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[MANIFESTATION] [OTHER] [NONE],"[MANIFESTATION]
[OTHER]
[NONE]",N/A,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:08:05,1643044809,5/25/2015 16:06:41,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],used in treating,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:08:59,1643045014,5/25/2015 16:07:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","OCTREOTIDE ACETATE A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",n/a,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540234,5/25/2015 16:09:01,1643045027,5/25/2015 16:06:24,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],OCTREOTIDE ACETATE treating ACROMEGALY,N/A,128,0,-1,137,18,TWrex-cause,803498-FS1,"OCTREOTIDE ACETATE    (                audio )  A synthetic drug that mimics the action of somatostatin and is used in treating ACROMEGALY carcinoid tumors, vasoactive intestinal peptide tumors, pancreatitis, and gastrointestinal bleeding.",ACROMEGALY,OCTREOTIDE ACETATE
725540235,5/25/2015 16:21:41,1643048540,5/25/2015 16:21:30,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 16:29:59,1643050314,5/25/2015 16:29:48,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],symptoms.,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 16:46:18,1643054014,5/25/2015 16:45:54,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CAUSES] [CONTRAINDICATES] [NONE],"[CAUSES]
[CONTRAINDICATES]
[NONE]",N/A,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 16:55:06,1643056407,5/25/2015 16:54:39,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CAUSES],[CAUSES],causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:04:31,1643060049,5/25/2015 17:04:12,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:09:35,1643062517,5/25/2015 17:09:10,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[CAUSES],[CAUSES],causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:09:37,1643062539,5/25/2015 17:09:13,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],"Occasionally, causing",N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:09:40,1643062570,5/25/2015 17:09:29,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:09:55,1643062673,5/25/2015 17:09:39,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[SIDE_EFFECT] [CONTRAINDICATES] [PART_OF] [OTHER] [NONE],"[CONTRAINDICATES]
[SIDE_EFFECT]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:10:21,1643062841,5/25/2015 17:10:02,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:18:32,1643066833,5/25/2015 17:18:05,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],causing,n/a,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:21:51,1643068332,5/25/2015 17:19:23,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[LOCATION],[LOCATION],causing,n/a,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:23:02,1643068898,5/25/2015 17:22:22,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[MANIFESTATION] [SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",ENDOMETRIOMA ruptures causing ACUTE ABDOMINAL PAIN,n/a,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:23:09,1643068961,5/25/2015 17:22:55,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [NONE],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540235,5/25/2015 17:28:15,1643071483,5/25/2015 17:27:16,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],causing,N/A,57,17,1,76,29,TWrex-cause,813574-FS1,"Occasionally, an ENDOMETRIOMA ruptures or leaks, causing ACUTE ABDOMINAL PAIN and peritoneal symptoms.",ACUTE ABDOMINAL PAIN,ENDOMETRIOMA
725540236,5/25/2015 16:30:48,1643050567,5/25/2015 16:30:35,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 16:47:25,1643054239,5/25/2015 16:47:13,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[LOCATION] [OTHER] [NONE],"[LOCATION]
[OTHER]
[NONE]",N/A,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 16:58:33,1643057559,5/25/2015 16:57:48,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:07:23,1643061397,5/25/2015 17:06:18,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],accompanied by,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:10:42,1643062961,5/25/2015 17:10:27,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[LOCATION] [MANIFESTATION] [IS_A] [OTHER] [NONE],"[LOCATION]
[MANIFESTATION]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:11:24,1643063317,5/25/2015 17:11:11,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",accompanied by,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:11:31,1643063435,5/25/2015 17:11:03,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:11:35,1643063477,5/25/2015 17:11:14,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[SYMPTOM],[SYMPTOM],accompanied by,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:13:18,1643064291,5/25/2015 17:12:15,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:21:53,1643068345,5/25/2015 17:20:14,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may be accompanied by,n/a,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:24:10,1643069459,5/25/2015 17:23:53,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [TREATS] [LOCATION] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]
[NONE]",N/A,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:25:13,1643069999,5/25/2015 17:24:31,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,n/a,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:27:28,1643071114,5/25/2015 17:25:41,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[ASSOCIATED_WITH],[ASSOCIATED_WITH],attacks of AIP may be accompanied by SEIZURES,n/a,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:31:28,1643072801,5/25/2015 17:30:46,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],accompanied by,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540236,5/25/2015 17:33:50,1643073793,5/25/2015 17:32:28,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,N/A,43,17,1,50,20,TWrex-cause,814789-FS1,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP
725540237,5/25/2015 15:55:41,1643042228,5/25/2015 15:55:15,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],within,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 15:57:49,1643042678,5/25/2015 15:57:37,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [CAUSES] [CONTRAINDICATES] [NONE],"[TREATS]
[CAUSES]
[CONTRAINDICATES]
[NONE]",N/A,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:02:37,1643043702,5/25/2015 16:01:59,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],subject variability INSULIN GLARGINE TYPE 1 DIABETES,NONE,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:10:23,1643045358,5/25/2015 16:10:09,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[CONTRAINDICATES],[CONTRAINDICATES],comparison,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:11:37,1643045829,5/25/2015 16:11:02,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[MANIFESTATION],[MANIFESTATION],INSULIN GLARGINE in people with TYPE 1 DIABETES,n/a,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:12:40,1643046094,5/25/2015 16:12:24,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[NONE] [SIDE_EFFECT] [CONTRAINDICATES],"[CONTRAINDICATES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:14:18,1643046671,5/25/2015 16:13:25,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in people with,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:16:18,1643047177,5/25/2015 16:16:05,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[LOCATION],[LOCATION],variability,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:21:22,1643048493,5/25/2015 16:20:13,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],variability of insulin,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:23:57,1643049048,5/25/2015 16:22:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES,n/a,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:24:33,1643049184,5/25/2015 16:24:22,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],within,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:25:54,1643049513,5/25/2015 16:24:11,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[TREATS],[TREATS],in people with,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:27:54,1643049862,5/25/2015 16:26:44,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],Lower,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:29:54,1643050306,5/25/2015 16:28:49,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in people with,N/A,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540237,5/25/2015 16:36:32,1643051546,5/25/2015 16:36:08,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],Lower within,n/a,150,118,-1,164,134,TWrex-cause,800424-FS1,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE
725540238,5/25/2015 15:21:49,1643032193,5/25/2015 15:21:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Adverse Effects,n/a,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:28:44,1643034206,5/25/2015 15:28:29,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SIDE_EFFECT],[SIDE_EFFECT],Effects,n/a,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:29:07,1643034364,5/25/2015 15:28:16,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",Adverse Effects CONJUNCTIVITIS DRY EYE,N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:32:07,1643035358,5/25/2015 15:31:53,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],"hyperemia,",N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:34:23,1643036005,5/25/2015 15:33:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Adverse Effects CONJUNCTIVITIS discharge, DRY EYE",na,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:36:00,1643036521,5/25/2015 15:35:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"CONJUNCTIVITIS discharge, DRY EYE",n/a,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:37:01,1643036820,5/25/2015 15:36:47,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[CAUSES] [MANIFESTATION] [PART_OF] [NONE],"[CAUSES]
[MANIFESTATION]
[PART_OF]
[NONE]",N/A,N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:37:38,1643036987,5/25/2015 15:37:16,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:40:17,1643037748,5/25/2015 15:39:40,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Common,N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:40:49,1643037924,5/25/2015 15:40:35,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],"discharge,",N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:40:53,1643037960,5/25/2015 15:40:05,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[CONTRAINDICATES],[CONTRAINDICATES],Common Adverse Effects,N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:42:36,1643038678,5/25/2015 15:42:16,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[MANIFESTATION],[MANIFESTATION],"Discomfort, tearing, edema, mouth,",N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:43:23,1643038910,5/25/2015 15:42:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],"CONJUNCTIVITIS discharge, DRY EYE",N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:43:21,1643038913,5/25/2015 15:42:46,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SIDE_EFFECT],[SIDE_EFFECT],"discharge,",N/A,183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540238,5/25/2015 15:44:11,1643039277,5/25/2015 15:42:40,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"as far as I can tell, they are all just listed together, maybe a list of side-effect, or a list of illnesses, it doesn't say",183,157,-1,189,171,TWrex-cause,802449-FS1,"c  Common Adverse Effects  0.5% solution: Discomfort, hyperemia, pruritus, tearing, lid edema, dry mouth, foreign body sensation, blanching, blurred vision, CONJUNCTIVITIS discharge, DRY EYE",DRY EYE,CONJUNCTIVITIS
725540239,5/25/2015 15:50:02,1643040953,5/25/2015 15:49:49,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [MANIFESTATION] [CONTRAINDICATES] [NONE],"[CAUSES]
[MANIFESTATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 15:52:46,1643041703,5/25/2015 15:52:31,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 15:54:00,1643041931,5/25/2015 15:52:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CELIAC DISEASE,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 15:54:31,1643042016,5/25/2015 15:54:12,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 15:54:46,1643042058,5/25/2015 15:54:36,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 15:57:03,1643042516,5/25/2015 15:56:48,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE,NONE,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:04:33,1643044150,5/25/2015 16:03:55,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CEREBELLAR ATAXIA associated with CELIAC DISEASE,n/a,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:04:42,1643044175,5/25/2015 16:03:29,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:07:20,1643044619,5/25/2015 16:07:08,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:07:44,1643044741,5/25/2015 16:07:32,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[PART_OF] [NONE] [OTHER],"[PART_OF]
[OTHER]
[NONE]",N/A,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:08:36,1643044941,5/25/2015 16:08:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:12:32,1643046065,5/25/2015 16:11:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.,n/a,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:12:31,1643046071,5/25/2015 16:11:52,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CEREBELLAR ATAXIA associated with CELIAC DISEASE,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:13:02,1643046244,5/25/2015 16:11:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540239,5/25/2015 16:14:25,1643046724,5/25/2015 16:14:11,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,81,127,1,97,141,TWrex-cause,813978-FS1,"3]  Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. CEREBELLAR ATAXIA associated with subclinical CELIAC DISEASE responding to gluten free diet.",CEREBELLAR ATAXIA,CELIAC DISEASE
725540240,5/25/2015 15:18:43,1643031406,5/25/2015 15:18:29,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis,n/a,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:21:08,1643032033,5/25/2015 15:20:18,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of rough or smooth PAPULE,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:25:52,1643033446,5/25/2015 15:25:39,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],consists of,n/a,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:27:54,1643034019,5/25/2015 15:26:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a PAPULE,na,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:29:34,1643034528,5/25/2015 15:28:59,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],centimeters,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:30:02,1643034705,5/25/2015 15:29:29,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis of,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:31:37,1643035229,5/25/2015 15:31:01,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"SEBORRHEIC KERATOSIS consists of a sharply circumscribed, rough or smooth PAPULE",n/a,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:32:58,1643035613,5/25/2015 15:32:32,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:33:27,1643035763,5/25/2015 15:32:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],consists of,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:33:47,1643035837,5/25/2015 15:33:27,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[CAUSES] [PREVENTS] [MANIFESTATION] [CONTRAINDICATES] [NONE],"[PREVENTS]
[CAUSES]
[MANIFESTATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:36:19,1643036651,5/25/2015 15:35:40,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:38:09,1643037124,5/25/2015 15:37:50,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:39:00,1643037344,5/25/2015 15:38:43,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SEBORRHEIC KERATOSIS (SEBORRHEIC PAPULE,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:39:50,1643037617,5/25/2015 15:39:17,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],consists of,n/a,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540240,5/25/2015 15:40:24,1643037792,5/25/2015 15:39:54,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis consists,N/A,103,11,1,108,49,TWrex-cause,813738-FS1,"Diagnosis  SEBORRHEIC KERATOSIS (SEBORRHEIC WART) consists of a sharply circumscribed, rough or smooth PAPULE or plaque that is 1 mm to several centimeters in size and dirty yellow or light to dark brown in color.",PAPULE,SEBORRHEIC KERATOSIS (SEBORRHEIC WART)
725540241,5/25/2015 16:20:15,1643048175,5/25/2015 16:20:00,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],symptoms,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:28:38,1643050106,5/25/2015 16:28:26,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],sensation,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:39:56,1643052442,5/25/2015 16:39:24,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[NONE],[NONE],N/a,Unrelated terms.,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:41:48,1643052955,5/25/2015 16:40:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",n/a,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:43:34,1643053420,5/25/2015 16:43:19,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[LOCATION] [CONTRAINDICATES] [ASSOCIATED_WITH] [IS_A] [OTHER] [NONE],"[LOCATION]
[CONTRAINDICATES]
[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:45:19,1643053821,5/25/2015 16:44:24,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[NONE],[NONE],N/A,photophobia is linked with uveitis,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:49:26,1643054732,5/25/2015 16:48:32,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],other symptoms,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 16:53:20,1643055913,5/25/2015 16:52:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,Different possible diagnoses,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:01:41,1643058817,5/25/2015 17:01:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],other symptoms,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:03:23,1643059553,5/25/2015 17:01:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],EYES;,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:05:13,1643060381,5/25/2015 17:04:29,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[SYMPTOM],[SYMPTOM],symptoms,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:06:38,1643061018,5/25/2015 17:06:05,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No direct relation.,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:06:49,1643061113,5/25/2015 17:06:36,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[MANIFESTATION] [SIDE_EFFECT] [PART_OF] [NONE],"[MANIFESTATION]
[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:07:10,1643061319,5/25/2015 17:06:40,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[NONE],[NONE],N/A,different conditions,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540241,5/25/2015 17:13:07,1643064197,5/25/2015 17:12:16,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[NONE],[NONE],other,other symptoms,230,281,-1,237,288,TWrex-cause,802053-FS1,"Itching suggests an allergic cause; nasal pain suggests dacryocystitis; constant foreign body sensation suggests a corneal foreign body, corneal abrasion, corneal ulcer, or trichiasis; intermittent foreign body sensation suggests DRY EYES; other symptoms (eg, photophobia) suggest UVEITIS or keratitis.",DRY EYES,UVEITIS
725540242,5/25/2015 16:30:32,1643050481,5/25/2015 16:30:20,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],decreasing,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 16:47:08,1643054202,5/25/2015 16:46:54,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [IS_A] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 16:57:47,1643057279,5/25/2015 16:56:41,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[LOCATION],[LOCATION],with,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:06:16,1643060855,5/25/2015 17:05:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],compress,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:10:24,1643062856,5/25/2015 17:10:12,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[ASSOCIATED_WITH] [PART_OF] [NONE] [OTHER],"[ASSOCIATED_WITH]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:11:01,1643063171,5/25/2015 17:10:17,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],with,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:11:09,1643063240,5/25/2015 17:10:10,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Relation not expressed by terms above mentioned.,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:11:12,1643063248,5/25/2015 17:10:42,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[LOCATION],[LOCATION],with,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:12:13,1643063730,5/25/2015 17:10:48,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[LOCATION],[LOCATION],lung with,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:20:12,1643067650,5/25/2015 17:19:11,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",decreasing air leakage and perhaps improving ventilation,n/a,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:23:51,1643069302,5/25/2015 17:23:36,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[PREVENTS] [SYMPTOM] [CONTRAINDICATES] [NONE],"[PREVENTS]
[SYMPTOM]
[CONTRAINDICATES]
[NONE]",N/A,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:24:28,1643069611,5/25/2015 17:23:28,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[LOCATION],[LOCATION],ventilation,n/a,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:25:39,1643070282,5/25/2015 17:23:49,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SYMPTOM] [LOCATION] [ASSOCIATED_WITH] [PART_OF],"[LOCATION]
[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA decreasing air leakage and improving ventilation of normal LUNG.,n/a,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:30:39,1643072395,5/25/2015 17:29:37,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[LOCATION],[LOCATION],with,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540242,5/25/2015 17:32:27,1643073174,5/25/2015 17:31:43,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],improving,N/A,330,207,-1,333,239,TWrex-cause,802971-FS1,"If one lung is significantly more involved than the other, the infant may be laid down on the side of the lung with the more severe pulmonary interstitial emphysema; this will help to compress the lung with PULMONARY INTERSTITIAL EMPHYSEMA thereby decreasing air leakage and perhaps improving ventilation of the normal (elevated) LUNG.",LUNG,PULMONARY INTERSTITIAL EMPHYSEMA
725540243,5/25/2015 15:48:07,1643040435,5/25/2015 15:47:50,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [ASSOCIATED_WITH] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:49:25,1643040799,5/25/2015 15:49:11,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],Antimicrobial therapy,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:49:32,1643040811,5/25/2015 15:49:11,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:50:43,1643041127,5/25/2015 15:50:00,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"improving Blood tests GLUCOSE renal failure,",NONE,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:51:39,1643041386,5/25/2015 15:51:01,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],To determine,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:52:24,1643041623,5/25/2015 15:51:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"pregnancy test, cultures) To determine underlying conditions",n/a,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:52:26,1643041627,5/25/2015 15:49:50,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Blood tests To determine,n/a,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 15:55:47,1643042248,5/25/2015 15:53:20,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"I can't tell, the sentence make NO sense to me",332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:00:50,1643043394,5/25/2015 15:59:58,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],GLUCOSE underlying conditions DEHYDRATION,n/a,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:04:15,1643044100,5/25/2015 16:02:34,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],tests,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:04:59,1643044199,5/25/2015 16:04:27,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],therapy,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:06:02,1643044370,5/25/2015 16:05:35,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [IS_A] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[NONE]",N/A,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:06:19,1643044422,5/25/2015 16:05:11,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SIDE_EFFECT],[SIDE_EFFECT],GLUCOSE underlying conditions DEHYDRATION,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:06:40,1643044490,5/25/2015 16:06:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],To determine the severity,N/A,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540243,5/25/2015 16:08:18,1643044903,5/25/2015 16:07:41,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"To determine the severity of infection underlying conditions such renal failure, DEHYDRATION diabetes, pregnancy.",n/a,332,202,1,342,209,TWrex-cause,812410-FS1,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE
725540244,5/25/2015 15:48:53,1643040631,5/25/2015 15:48:41,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PREVENTS] [SIDE_EFFECT] [NONE],"[PREVENTS]
[SIDE_EFFECT]
[NONE]",N/A,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:50:09,1643040980,5/25/2015 15:49:55,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],Treatment,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:50:17,1643041032,5/25/2015 15:49:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],OLANZAPINE,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:52:38,1643041669,5/25/2015 15:52:12,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],is indicated treatment,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:53:12,1643041786,5/25/2015 15:52:42,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],integral part of a total treatment program,n/a,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:53:15,1643041793,5/25/2015 15:52:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],integral part of total treatment,n/a,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:54:09,1643041947,5/25/2015 15:52:40,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],OLANZAPINE integral part total treatment program BIPOLAR DISORDER,NONE,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 15:57:26,1643042611,5/25/2015 15:56:38,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],integral part of a total treatment program for,n/a,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:01:58,1643043588,5/25/2015 16:01:31,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],OLANZAPINE is indicated as treatment for BIPOLAR DISORDER,n/a,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:06:04,1643044376,5/25/2015 16:05:50,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],Treatment,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:06:36,1643044463,5/25/2015 16:05:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],is indicated as an integral part of a total treatment,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:06:44,1643044523,5/25/2015 16:06:31,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[MANIFESTATION] [OTHER] [NONE],"[MANIFESTATION]
[OTHER]
[NONE]",N/A,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:08:51,1643044972,5/25/2015 16:08:19,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as integral part of total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER,n/a,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:08:56,1643044999,5/25/2015 16:08:07,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment program,N/A,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540244,5/25/2015 16:10:17,1643045347,5/25/2015 16:09:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",n/a,198,79,-1,213,89,TWrex-cause,800310-FS1,"Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: OLANZAPINE is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and BIPOLAR DISORDER that may include other measures (psychological, educational, social) for patients with the disorder.",BIPOLAR DISORDER,OLANZAPINE
725540245,5/25/2015 15:18:09,1643031280,5/25/2015 15:17:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment,n/a,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:19:17,1643031546,5/25/2015 15:18:46,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:25:23,1643033350,5/25/2015 15:25:13,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:26:12,1643033529,5/25/2015 15:25:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS,na,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:28:41,1643034192,5/25/2015 15:28:26,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],Treatment,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:28:43,1643034196,5/25/2015 15:28:03,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],Treatment of,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:30:28,1643034835,5/25/2015 15:30:01,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],MYCOBACTERIUM KANSASII Caused by Rifampin susceptible M. kansasii,n/a,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:30:46,1643034946,5/25/2015 15:29:40,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],and Other MYCOBACTERIAL INFECTIONS,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:32:05,1643035356,5/25/2015 15:31:44,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:33:02,1643035620,5/25/2015 15:32:51,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[LOCATION] [SIDE_EFFECT] [PART_OF] [OTHER] [NONE],"[LOCATION]
[SIDE_EFFECT]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:35:17,1643036319,5/25/2015 15:34:32,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:37:24,1643036928,5/25/2015 15:37:10,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],Treatment,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:38:12,1643037150,5/25/2015 15:37:48,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],MYCOBACTERIAL INFECTIONS,N/A,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:38:56,1643037335,5/25/2015 15:38:07,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],and Other,n/a,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540245,5/25/2015 15:39:13,1643037437,5/25/2015 15:38:37,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Other INFECTIONS,n/a,44,11,1,67,33,TWrex-cause,812411-FS1,"108 ,   c  MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS   +  >     Treatment of Pulmonary or Disseminated Infections Caused by Rifampin susceptible M. kansasii  +  Oral:  15 mg/kg once daily in conjunction with rifampin (10 mg/kg [up to 600 mg] daily), isoniazid (5 mg/kg [up to 300 mg] daily), and pyridoxine (50 mg daily) recommended by ATS and IDSA.",MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725540246,5/25/2015 15:21:08,1643032031,5/25/2015 15:20:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:27:33,1643033969,5/25/2015 15:26:51,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],NEUTROPENIA can occur with VANCOMYCIN,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:28:13,1643034092,5/25/2015 15:27:52,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can occur,n/a,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:31:35,1643035214,5/25/2015 15:31:24,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:33:24,1643035750,5/25/2015 15:31:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],NEUTROPENIA can occur with VANCOMYCIN,na,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:34:54,1643036216,5/25/2015 15:34:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],NEUTROPENIA can occur during therapy with VANCOMYCIN,n/a,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:35:56,1643036510,5/25/2015 15:35:41,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [ASSOCIATED_WITH] [NONE],"[PREVENTS]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:36:45,1643036749,5/25/2015 15:36:12,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:38:13,1643037154,5/25/2015 15:37:37,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[SYMPTOM],[SYMPTOM],can occur,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:39:18,1643037503,5/25/2015 15:39:06,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],therapy,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:40:19,1643037765,5/25/2015 15:40:06,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:41:34,1643038239,5/25/2015 15:40:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],can occur,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:41:47,1643038306,5/25/2015 15:41:25,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"with cephalosporins, VANCOMYCIN",N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:42:44,1643038715,5/25/2015 15:42:21,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],therapy with,N/A,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540246,5/25/2015 15:43:00,1643038825,5/25/2015 15:42:18,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],during therapy with,n/a,0,74,-1,10,84,TWrex-cause,800555-FS1,"NEUTROPENIA can occur during therapy with penicillins, cephalosporins, or VANCOMYCIN",NEUTROPENIA,VANCOMYCIN
725540247,5/25/2015 15:47:47,1643040314,5/25/2015 15:47:28,false,elite,1,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],"DEPRESSION disorders, commonly treatable.",N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:47:48,1643040331,5/25/2015 15:47:34,false,elite,1,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [SIDE_EFFECT] [NONE],"[CAUSES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:49:07,1643040691,5/25/2015 15:48:48,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatable.,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:49:09,1643040695,5/25/2015 15:48:37,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],DEPRESSION,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:49:49,1643040872,5/25/2015 15:49:30,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],commonly coexist with,n/a,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:49:59,1643040944,5/25/2015 15:49:31,false,neodev,1,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Psychiatric especially DEPRESSION MS are treatable.,NONE,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:50:46,1643041128,5/25/2015 15:49:51,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[IS_A],[IS_A],are,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:51:02,1643041185,5/25/2015 15:50:26,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],commonly coexist with,n/a,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:53:15,1643041795,5/25/2015 15:52:33,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",commonly coexist with,n/a,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 15:59:57,1643043285,5/25/2015 15:59:14,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,[PART_OF],[PART_OF],DEPRESSION commonly coexist with MS,n/a,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 16:02:28,1643043697,5/25/2015 16:01:58,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],commonly coexist with,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 16:04:22,1643044120,5/25/2015 16:04:08,false,elite,1,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatable.,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 16:05:10,1643044217,5/25/2015 16:04:33,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",DEPRESSION coexist with MS,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 16:05:56,1643044345,5/25/2015 16:04:44,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],commonly coexist,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540247,5/25/2015 16:10:50,1643045505,5/25/2015 16:10:37,false,elite,1,31528450,USA,CA,Napa,38.110.180.195,[IS_A] [NONE],"[IS_A]
[NONE]",N/A,N/A,35,103,1,44,105,TWrex-cause,812811-FS1,"• Psychiatric problems, especially DEPRESSION anxiety, and adjustment disorders, commonly coexist with MS and are treatable.",DEPRESSION,MS
725540248,5/25/2015 15:08:46,1643029380,5/25/2015 15:08:37,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.136,[CONTRAINDICATES],[CONTRAINDICATES],should be avoided,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:11:25,1643029861,5/25/2015 15:10:53,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[CONTRAINDICATES],[CONTRAINDICATES],METRONIDAZOLE should be avoided during PREGNANCY,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:14:57,1643030702,5/25/2015 15:14:40,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],avoided,n/a,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:20:12,1643031714,5/25/2015 15:18:59,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],should be avoided,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:20:31,1643031866,5/25/2015 15:19:52,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],METRONIDAZOLE should be avoided during PREGNANCY,na,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:20:42,1643031926,5/25/2015 15:19:59,false,points4rewards,1,28703583,USA,"","",97.73.93.107,[CONTRAINDICATES],[CONTRAINDICATES],should be avoided,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:22:12,1643032318,5/25/2015 15:21:52,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[LOCATION],[LOCATION],of,http://www.expedia.com/Abu-Dhabi-Emirate-Hotels-Howard-Johnson-Hotel-Diplomat-Abu-Dhabi-AE.h533280.Hotel-Information,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:26:06,1643033499,5/25/2015 15:25:52,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],because,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:26:53,1643033767,5/25/2015 15:26:15,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],METRONIDAZOLE should be avoided during PREGNANCY,n/a,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:27:44,1643033995,5/25/2015 15:27:21,false,neodev,1,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:28:38,1643034190,5/25/2015 15:27:28,false,neodev,1,27039189,NLD,03,Warnsveld,213.93.50.164,[CONTRAINDICATES],[CONTRAINDICATES],should be avoided,n/a,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:29:35,1643034532,5/25/2015 15:29:03,false,bitcoinget,1,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],avoided,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:29:39,1643034540,5/25/2015 15:28:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CONTRAINDICATES],[CONTRAINDICATES],should be avoided,n/a,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:30:37,1643034879,5/25/2015 15:30:15,false,elite,1,31536964,USA,CA,Berkeley,67.180.156.186,[MANIFESTATION] [NONE],"[MANIFESTATION]
[NONE]",N/A,N/A,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540248,5/25/2015 15:31:19,1643035112,5/25/2015 15:30:47,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],concerns about its mutagenicity.,n/a,167,107,-1,175,120,TWrex-cause,803307-FS1,"Although metronidazole is in the FDA category B (meaning the drug is unlikely to be harmful to the fetus), METRONIDAZOLE should be avoided during the 1st trimester of PREGNANCY because of concerns about its mutagenicity.",PREGNANCY,METRONIDAZOLE
725540249,5/25/2015 15:57:25,1643042605,5/25/2015 15:57:13,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:11:39,1643045837,5/25/2015 16:11:26,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[CAUSES],[CAUSES],caused,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:13:39,1643046461,5/25/2015 16:13:23,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CAUSES],[CAUSES],GLANDERS caused by B MALLEI,n/a,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:15:39,1643047004,5/25/2015 16:15:26,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[MANIFESTATION] [OTHER] [NONE],"[MANIFESTATION]
[OTHER]
[NONE]",N/A,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:17:29,1643047512,5/25/2015 16:17:17,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],caused,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:18:07,1643047762,5/25/2015 16:17:41,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:26:10,1643049555,5/25/2015 16:25:56,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:28:38,1643050107,5/25/2015 16:27:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:29:19,1643050184,5/25/2015 16:28:35,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Altenative for treatment of GLANDERS + caused by B MALLEI,n/a,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:32:17,1643050958,5/25/2015 16:31:16,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],caused by,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:32:20,1643050961,5/25/2015 16:31:42,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],caused,N/a,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:34:59,1643051159,5/25/2015 16:32:58,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[CAUSES],[CAUSES],caused,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:39:19,1643052311,5/25/2015 16:38:51,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[IS_A] [NONE],"[IS_A]
[NONE]",N/A,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:39:51,1643052433,5/25/2015 16:39:13,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CAUSES],[CAUSES],caused by,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540249,5/25/2015 16:51:50,1643055543,5/25/2015 16:51:32,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[OTHER],[OTHER],treatment of GLANDERS + caused by B MALLEI,N/A,57,84,1,64,92,TWrex-cause,810912-FS1,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI
725540250,5/25/2015 15:56:42,1643042452,5/25/2015 15:56:29,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],are,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 15:58:37,1643042873,5/25/2015 15:58:11,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [SIDE_EFFECT] [IS_A] [NONE],"[CAUSES]
[SIDE_EFFECT]
[IS_A]
[NONE]",N/A,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:03:54,1643044035,5/25/2015 16:03:28,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CONTRAINDICATES],[CONTRAINDICATES],ACUTE TYPHOID INFECTION should not receive TYPHOID VACCINE,NONE,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:10:53,1643045509,5/25/2015 16:10:41,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[CAUSES],[CAUSES],typhoid,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:12:20,1643046017,5/25/2015 16:12:02,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CONTRAINDICATES],[CONTRAINDICATES],ACUTE TYPHOID INFECTION should not receive TYPHOID VACCINE,n/a,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:13:41,1643046466,5/25/2015 16:13:04,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[ASSOCIATED_WITH] [SYMPTOM] [OTHER] [NONE],"[SYMPTOM]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:16:08,1643047078,5/25/2015 16:15:13,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CONTRAINDICATES],[CONTRAINDICATES],should not receive,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:16:45,1643047272,5/25/2015 16:16:33,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],chronic,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:24:20,1643049130,5/25/2015 16:22:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],should not receive,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:25:26,1643049414,5/25/2015 16:24:50,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],those,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:26:19,1643049585,5/25/2015 16:25:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should not receive TYPHOID VACCINE,n/a,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:28:25,1643050062,5/25/2015 16:27:32,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[CONTRAINDICATES],[CONTRAINDICATES],should not receive,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:29:50,1643050272,5/25/2015 16:28:33,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[CONTRAINDICATES],[CONTRAINDICATES],should not receive,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:30:52,1643050593,5/25/2015 16:30:21,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[PREVENTS],[PREVENTS],ACUTE TYPHOID INFECTION TYPHOID VACCINE,N/a,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540250,5/25/2015 16:38:03,1643051928,5/25/2015 16:37:28,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CAUSES] [TREATS] [MANIFESTATION] [NONE],"[TREATS]
[CAUSES]
[MANIFESTATION]
[NONE]",N/A,N/A,22,110,-1,44,125,TWrex-cause,805299-FS1,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE
725540251,5/25/2015 16:50:53,1643055257,5/25/2015 16:49:46,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CONTRAINDICATES] [IS_A] [NONE],"[CONTRAINDICATES]
[IS_A]
[NONE]",N/A,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:02:39,1643059245,5/25/2015 17:02:08,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[MANIFESTATION],[MANIFESTATION],Reactivation of,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:12:45,1643064055,5/25/2015 17:12:31,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CAUSES] [SIDE_EFFECT] [OTHER] [NONE],"[CAUSES]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:14:02,1643064612,5/25/2015 17:13:32,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation.,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:14:14,1643064709,5/25/2015 17:13:53,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[CAUSES],[CAUSES],Reactivation of,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:15:51,1643065536,5/25/2015 17:14:20,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],VIRUS,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:19:23,1643067229,5/25/2015 17:17:39,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Reactivation,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:27:41,1643071184,5/25/2015 17:27:03,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[MANIFESTATION] [PART_OF] [OTHER] [NONE],"[MANIFESTATION]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:30:11,1643072214,5/25/2015 17:29:40,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[PART_OF],[PART_OF],Reactivation,n/a,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:30:36,1643072381,5/25/2015 17:29:50,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[OTHER] [CAUSES],"[CAUSES]
[OTHER]",Reactivation of,n/a,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:36:09,1643075095,5/25/2015 17:35:29,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],Reactivation,N/A,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:36:25,1643075197,5/25/2015 17:34:27,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[NONE],[NONE],n/a,too vague to even guess,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:38:08,1643076074,5/25/2015 17:37:33,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[CAUSES],[CAUSES],Reactivation,n/a,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:39:05,1643076784,5/25/2015 17:38:32,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],Reactivation,n/a,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540251,5/25/2015 17:47:15,1643081354,5/25/2015 17:45:58,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,[NONE],[NONE],n/a,doesn't seem related,0,27,1,5,42,TWrex-cause,814960-FS1,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS
725540252,5/25/2015 16:20:58,1643048394,5/25/2015 16:20:46,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 16:29:18,1643050178,5/25/2015 16:29:07,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 16:44:28,1643053652,5/25/2015 16:44:15,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[PREVENTS] [CONTRAINDICATES] [IS_A] [NONE],"[PREVENTS]
[CONTRAINDICATES]
[IS_A]
[NONE]",N/A,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 16:48:01,1643054341,5/25/2015 16:47:16,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],treatment in the,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 16:52:19,1643055628,5/25/2015 16:51:02,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"similar between treatment groups,",N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:02:58,1643059376,5/25/2015 17:02:41,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],in,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:07:14,1643061368,5/25/2015 17:06:28,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],treatment,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:07:15,1643061372,5/25/2015 17:05:18,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],"treatment groups,",N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:08:10,1643061800,5/25/2015 17:07:49,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[LOCATION] [SIDE_EFFECT] [PART_OF] [OTHER] [NONE],"[LOCATION]
[SIDE_EFFECT]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:08:12,1643061805,5/25/2015 17:07:39,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[MANIFESTATION],[MANIFESTATION],in,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:08:30,1643061890,5/25/2015 17:08:00,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[CAUSES],[CAUSES],breakthrough,N/A,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:11:43,1643063556,5/25/2015 17:11:35,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.248.31,[NONE],[NONE],no,no,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:15:20,1643065249,5/25/2015 17:14:05,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],treatment,n/a,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:16:38,1643065839,5/25/2015 17:15:10,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[LOCATION],[LOCATION],in,n/a,98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540252,5/25/2015 17:20:17,1643067711,5/25/2015 17:19:07,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[NONE],[NONE],n/a,"upon review, no real connection",98,123,-1,114,153,TWrex-cause,804403-FS1,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP
725540253,5/25/2015 16:21:13,1643048453,5/25/2015 16:21:00,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],dabigatran,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 16:29:31,1643050225,5/25/2015 16:29:20,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],fibrillation.,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 16:44:51,1643053693,5/25/2015 16:44:36,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CAUSES] [CONTRAINDICATES] [PART_OF] [NONE],"[CAUSES]
[CONTRAINDICATES]
[PART_OF]
[NONE]",N/A,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 16:53:00,1643055783,5/25/2015 16:52:27,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[PREVENTS],[PREVENTS],reduced,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 16:58:43,1643057627,5/25/2015 16:57:32,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],reduced,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:03:35,1643059595,5/25/2015 17:02:59,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],reduced,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:07:55,1643061656,5/25/2015 17:07:16,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],dose,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:08:06,1643061749,5/25/2015 17:07:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Therapeutics,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:08:45,1643062065,5/25/2015 17:08:13,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No direct relation.,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:09:07,1643062290,5/25/2015 17:08:20,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[TREATS] [CAUSES] [MANIFESTATION] [NONE] [OTHER],"[TREATS]
[CAUSES]
[MANIFESTATION]
[OTHER]
[NONE]",N/A,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:09:23,1643062457,5/25/2015 17:08:31,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[PREVENTS],[PREVENTS],reduced,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:16:30,1643065797,5/25/2015 17:15:22,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],reduced,n/a,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:18:01,1643066604,5/25/2015 17:16:44,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[PART_OF],[PART_OF],"hemorrhage,",n/a,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:21:18,1643068125,5/25/2015 17:20:20,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[PREVENTS],[PREVENTS],"reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",n/a,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540253,5/25/2015 17:25:05,1643069955,5/25/2015 17:24:32,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[LOCATION] [PART_OF] [CONTRAINDICATES] [NONE],"[LOCATION]
[CONTRAINDICATES]
[PART_OF]
[NONE]",N/A,N/A,82,125,-1,87,133,TWrex-cause,804645-FS1,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN
725540254,5/25/2015 16:49:43,1643054847,5/25/2015 16:48:49,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[LOCATION] [ASSOCIATED_WITH] [OTHER] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:02:05,1643058988,5/25/2015 17:01:44,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CAUSES],[CAUSES],caused by,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:12:29,1643063880,5/25/2015 17:12:05,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CONTRAINDICATES] [IS_A] [PART_OF] [OTHER] [NONE],"[CONTRAINDICATES]
[IS_A]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:13:31,1643064420,5/25/2015 17:13:19,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],caused by,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:13:51,1643064544,5/25/2015 17:13:33,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[CAUSES],[CAUSES],caused by,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:14:18,1643064731,5/25/2015 17:14:01,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:17:37,1643066373,5/25/2015 17:17:12,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[CAUSES],[CAUSES],caused,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:27:00,1643070903,5/25/2015 17:25:59,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:28:38,1643071623,5/25/2015 17:28:18,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],caused by,n/a,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:29:30,1643071949,5/25/2015 17:28:58,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[MANIFESTATION],[MANIFESTATION],caused,n/a,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:34:26,1643074257,5/25/2015 17:32:32,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[CAUSES],[CAUSES],Treatment of external genital WARTS (CONDYLOMATA ACUMINATA) caused by HPV,n/a,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:35:16,1643074622,5/25/2015 17:34:32,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],caused by,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:35:26,1643074738,5/25/2015 17:34:57,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:37:30,1643075727,5/25/2015 17:35:28,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[CAUSES],[CAUSES],caused,n/a,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540254,5/25/2015 17:38:00,1643075986,5/25/2015 17:37:46,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused,n/a,53,93,1,81,96,TWrex-cause,810520-FS1,Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA) caused by HPV,WARTS (CONDYLOMATA ACUMINATA),HPV
725540255,5/25/2015 15:13:14,1643030248,5/25/2015 15:12:46,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],CNS primarily causes ENCEPHALITIS,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:15:38,1643030793,5/25/2015 15:15:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:21:30,1643032129,5/25/2015 15:21:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],CNS causes ENCEPHALITIS,na,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:22:43,1643032533,5/25/2015 15:22:14,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[CAUSES],[CAUSES],primarily causes,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:22:56,1643032602,5/25/2015 15:21:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],affecting the CNS primarily,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:22:58,1643032664,5/25/2015 15:22:31,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causes,n/a,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:26:48,1643033749,5/25/2015 15:26:34,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],causes,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:27:42,1643033989,5/25/2015 15:27:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],CNS primarily causes an ENCEPHALITIS,n/a,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:28:30,1643034178,5/25/2015 15:28:12,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causes,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:31:08,1643035072,5/25/2015 15:30:55,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [NONE] [OTHER],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]
[NONE]",N/A,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:31:08,1643035076,5/25/2015 15:30:51,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],causes,N/A,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:31:13,1643035094,5/25/2015 15:30:25,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],primarily causes an,n/a,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:31:52,1643035339,5/25/2015 15:31:42,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],causes,-,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:32:23,1643035446,5/25/2015 15:30:51,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],primarily causes an,n/a,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540255,5/25/2015 15:33:47,1643035838,5/25/2015 15:32:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],primarily causes,n/a,29,53,-1,31,65,TWrex-cause,802622-FS1,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS
725540256,5/25/2015 15:21:27,1643032104,5/25/2015 15:21:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Other features of,n/a,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:28:15,1643034111,5/25/2015 15:27:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],features of STURGE WEBER SYNDROME include CONTRALATERAL SEIZURES,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:28:27,1643034172,5/25/2015 15:28:14,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],anda,n/a,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:31:51,1643035338,5/25/2015 15:31:37,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:33:52,1643035878,5/25/2015 15:33:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],Other features of STURGE WEBER SYNDROME include CONTRALATERAL SEIZURES,na,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:35:39,1643036436,5/25/2015 15:34:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,n/a,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:36:46,1643036752,5/25/2015 15:35:59,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT] [PART_OF] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:37:14,1643036867,5/25/2015 15:36:47,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],include,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:39:39,1643037574,5/25/2015 15:39:20,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],features,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:39:52,1643037615,5/25/2015 15:38:19,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[CAUSES],[CAUSES],caused by,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:40:33,1643037838,5/25/2015 15:40:21,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:42:10,1643038496,5/25/2015 15:41:50,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[PREVENTS],[PREVENTS],STURGE ipsilateral CONTRALATERAL SEIZURES,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:42:18,1643038547,5/25/2015 15:41:36,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],features of,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:43:19,1643038908,5/25/2015 15:42:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],Other features include,n/a,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540256,5/25/2015 15:44:01,1643039206,5/25/2015 15:42:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],WEBER SYNDROME,N/A,75,22,1,134,43,TWrex-cause,813359-FS1,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME
725540257,5/25/2015 16:17:05,1643047371,5/25/2015 16:16:52,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[CAUSES] [NONE] [IS_A] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]
[IS_A]
[NONE]",N/A,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:18:46,1643047876,5/25/2015 16:18:32,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],caused,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:27:25,1643049738,5/25/2015 16:26:51,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:32:24,1643050976,5/25/2015 16:30:40,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],result from,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:35:35,1643051382,5/25/2015 16:32:51,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,n/a,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:37:02,1643051693,5/25/2015 16:36:21,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],may result from,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:37:34,1643051834,5/25/2015 16:37:11,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],may result from,N/a,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:41:17,1643052797,5/25/2015 16:40:57,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[MANIFESTATION] [PART_OF] [NONE],"[MANIFESTATION]
[PART_OF]
[NONE]",N/A,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:43:43,1643053482,5/25/2015 16:42:37,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[CAUSES],[CAUSES],caused by,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:50:26,1643055115,5/25/2015 16:50:10,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:57:46,1643057289,5/25/2015 16:56:48,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],may result from,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 16:58:24,1643057479,5/25/2015 16:58:01,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],may result from,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 17:00:21,1643058225,5/25/2015 16:59:00,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[CAUSES],[CAUSES],caused,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 17:01:56,1643058951,5/25/2015 17:01:25,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],result from,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540257,5/25/2015 17:04:52,1643060227,5/25/2015 17:04:21,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[SYMPTOM],[SYMPTOM],may result from,N/A,13,41,1,23,72,TWrex-cause,811853-FS1,Headache and PAPILLEDEMA may result from INCREASED INTRACRANIAL PRESSURE caused by meningeal infiltration and obstruction of the outflow of cerebrospinal fluid (CSF.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725540258,5/25/2015 16:51:07,1643055312,5/25/2015 16:50:56,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[MANIFESTATION] [SIDE_EFFECT] [OTHER] [NONE],"[MANIFESTATION]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:03:09,1643059461,5/25/2015 17:02:40,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],treatment,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:13:03,1643064162,5/25/2015 17:12:48,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[SYMPTOM] [SIDE_EFFECT] [OTHER] [NONE],"[SYMPTOM]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:14:45,1643064985,5/25/2015 17:14:16,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[NONE],[NONE],N/A,different conditions,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:14:55,1643065055,5/25/2015 17:14:03,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],treatment for,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:16:11,1643065638,5/25/2015 17:15:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:20:16,1643067687,5/25/2015 17:19:24,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:27:59,1643071347,5/25/2015 17:27:45,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[SIDE_EFFECT] [OTHER] [NONE],"[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:31:26,1643072764,5/25/2015 17:30:41,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",treatment,n/a,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:36:39,1643075296,5/25/2015 17:36:13,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:37:59,1643075963,5/25/2015 17:36:30,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],open clinical trial evaluated effects of treatment on women with LEUPROLIDE ACETATE for UTERINE FIBROIDS,n/a,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:38:55,1643076690,5/25/2015 17:38:09,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],clinical trial,n/a,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:39:43,1643077113,5/25/2015 17:39:07,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],and tibolone,n/a,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:44:27,1643079705,5/25/2015 17:43:17,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],effects of 2 year treatment for UTERINE,n/a,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540258,5/25/2015 17:47:56,1643081721,5/25/2015 17:47:17,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,[TREATS],[TREATS],treatment,n/a,131,95,-1,146,113,TWrex-cause,800845-FS1,• A prospective open clinical trial evaluated the effects of 2 year treatment on 25 women with LEUPROLIDE ACETATE and tibolone for UTERINE FIBROIDS,UTERINE FIBROIDS,LEUPROLIDE ACETATE
725540259,5/25/2015 15:56:55,1643042483,5/25/2015 15:56:44,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 15:58:52,1643042904,5/25/2015 15:58:39,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [SIDE_EFFECT] [NONE],"[LOCATION]
[SIDE_EFFECT]
[NONE]",N/A,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:11:09,1643045627,5/25/2015 16:10:55,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatment,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:12:42,1643046105,5/25/2015 16:12:22,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B,n/a,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:13:56,1643046554,5/25/2015 16:13:42,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[PART_OF] [NONE],"[PART_OF]
[NONE]",N/A,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:16:35,1643047217,5/25/2015 16:16:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of with,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:16:59,1643047357,5/25/2015 16:16:46,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:25:09,1643049339,5/25/2015 16:24:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:25:41,1643049469,5/25/2015 16:25:28,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:27:09,1643049697,5/25/2015 16:26:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.,n/a,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:29:05,1643050162,5/25/2015 16:28:27,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],treatment of with,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:31:04,1643050631,5/25/2015 16:29:52,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:31:14,1643050658,5/25/2015 16:30:56,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],treatment of,N/a,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:38:10,1643051980,5/25/2015 16:37:34,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],Short course treatment,n/a,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540259,5/25/2015 16:38:30,1643052082,5/25/2015 16:38:05,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[PART_OF] [SYMPTOM] [OTHER] [NONE],"[SYMPTOM]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,70,98,-1,91,122,TWrex-cause,800170-FS1,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
725540260,5/25/2015 15:23:10,1643032719,5/25/2015 15:22:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:32:01,1643035350,5/25/2015 15:31:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,none fit,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:33:25,1643035755,5/25/2015 15:33:08,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:36:47,1643036767,5/25/2015 15:36:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MALATHION LICE,na,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:37:42,1643036993,5/25/2015 15:37:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],for treatment of MALATHION Bug busting RRR Live LICE,n/a,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:38:52,1643037330,5/25/2015 15:38:37,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[SYMPTOM] [ASSOCIATED_WITH] [MANIFESTATION] [PART_OF] [NONE],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:40:56,1643037991,5/25/2015 15:40:27,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:41:48,1643038317,5/25/2015 15:41:17,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],+,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:42:15,1643038534,5/25/2015 15:42:04,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:44:25,1643039304,5/25/2015 15:44:06,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],head Outcome MALATHION treatment Abbreviations Glossary,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:44:58,1643039417,5/25/2015 15:44:29,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],for treatment of,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:45:02,1643039445,5/25/2015 15:44:40,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment of,n/a,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:45:16,1643039510,5/25/2015 15:44:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for treatment of head lice,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:45:23,1643039560,5/25/2015 15:44:58,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [PART_OF] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[PART_OF]
[NONE]",N/A,N/A,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540260,5/25/2015 15:45:42,1643039679,5/25/2015 15:44:37,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for treatment of,n/a,164,101,-1,167,110,TWrex-cause,803323-FS1,"Malathion lotion vs bug busting for treatment of head lice in children +  Outcome                    MALATHION     Bug busting     RRR (95% CI)       NNT (CI) Live LICE at 7 d after   23%         63%           64% (34 to 81)   2 (2 to 6) treatment  + Abbreviations defined in  Glossary ; RRR, NNT, and CI calculated from data in article.",LICE,MALATHION
725540261,5/25/2015 15:57:54,1643042716,5/25/2015 15:57:42,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],increases,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:12:29,1643046058,5/25/2015 16:11:58,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[SYMPTOM],[SYMPTOM],increases,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:14:24,1643046701,5/25/2015 16:14:04,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],WARFARIN risk INTRACEREBRAL HEMORRHAGE,n/a,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:16:36,1643047218,5/25/2015 16:16:20,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[NONE] [IS_A] [ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:18:14,1643047784,5/25/2015 16:17:59,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],patients,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:19:32,1643048058,5/25/2015 16:18:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],the risk for,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:26:36,1643049631,5/25/2015 16:26:25,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],patients,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:29:59,1643050313,5/25/2015 16:29:00,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],risk for,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:31:43,1643050753,5/25/2015 16:30:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CONTRAINDICATES],[CONTRAINDICATES],"In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5 (1).",n/a,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:35:31,1643051364,5/25/2015 16:32:59,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],risk increases significantly,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:36:44,1643051566,5/25/2015 16:36:13,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[CAUSES],[CAUSES],"the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases",N/a,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:40:17,1643052532,5/25/2015 16:40:02,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CAUSES] [OTHER] [NONE],"[CAUSES]
[OTHER]
[NONE]",N/A,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:41:02,1643052729,5/25/2015 16:40:20,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[MANIFESTATION],[MANIFESTATION],increases significantly,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:49:58,1643054911,5/25/2015 16:49:31,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CONTRAINDICATES],[CONTRAINDICATES],"In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly",N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540261,5/25/2015 16:50:56,1643055261,5/25/2015 16:50:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],risk for,N/A,79,31,1,102,39,TWrex-cause,810133-FS1,"COMMENTARY  In patients taking WARFARIN the risk for major bleeding, including INTRACEREBRAL HEMORRHAGE increases significantly with INRs ≥ 4.5  (1).",INTRACEREBRAL HEMORRHAGE,WARFARIN
725540262,5/25/2015 15:49:09,1643040697,5/25/2015 15:48:55,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[SYMPTOM] [OTHER] [NONE],"[SYMPTOM]
[OTHER]
[NONE]",N/A,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:50:30,1643041119,5/25/2015 15:50:19,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],DRUG TOXICITY,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:50:48,1643041145,5/25/2015 15:50:14,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],potential,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:53:15,1643041792,5/25/2015 15:52:41,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SIDE_EFFECT],[SIDE_EFFECT],can damage,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:53:44,1643041876,5/25/2015 15:53:14,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],can damage,n/a,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:53:43,1643041878,5/25/2015 15:53:18,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],potential for toxicity,n/a,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:55:36,1643042224,5/25/2015 15:54:59,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIRECT DRUG TOXICITY widely from drug to DRUG.,NONE,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 15:59:22,1643043036,5/25/2015 15:57:27,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],varies widely from,n/a,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:02:51,1643043787,5/25/2015 16:01:59,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIRECT DRUG TOXICITY potential for toxicity DRUG.,n/a,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:06:26,1643044441,5/25/2015 16:06:11,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],damage,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:06:59,1643044541,5/25/2015 16:06:46,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[NONE] [CONTRAINDICATES] [SYMPTOM],"[SYMPTOM]
[CONTRAINDICATES]
[NONE]",N/A,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:07:08,1643044562,5/25/2015 16:06:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],the potential for,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:09:40,1643045241,5/25/2015 16:09:03,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",DIRECT DRUG TOXICITY toxicity drug DRUG.,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:10:04,1643045298,5/25/2015 16:08:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],potential for toxicity,N/A,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540262,5/25/2015 16:10:20,1643045349,5/25/2015 16:08:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"DRUG TOXICITY Although antimicrobials can damage virtually all human organ systems,",n/a,0,7,1,19,11,TWrex-cause,812433-FS1,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG
725540263,5/25/2015 15:22:18,1643032371,5/25/2015 15:22:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment,n/a,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:29:14,1643034401,5/25/2015 15:29:06,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:30:31,1643034851,5/25/2015 15:30:10,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],Treatment of HYPERTENSION with METHYLDOPA:,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:32:36,1643035543,5/25/2015 15:32:24,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],Treatment,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:35:16,1643036314,5/25/2015 15:34:57,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Treatment of HYPERTENSION with METHYLDOPA:,na,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:36:48,1643036794,5/25/2015 15:36:27,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Treatment of HYPERTENSION in pregnancy with METHYLDOPA:,n/a,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:37:33,1643036986,5/25/2015 15:37:18,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:38:37,1643037277,5/25/2015 15:38:13,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:40:52,1643037948,5/25/2015 15:40:41,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],Treatment,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:41:34,1643038249,5/25/2015 15:41:21,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],pregnancy,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:42:27,1643038582,5/25/2015 15:42:01,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],Treatment of,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:43:21,1643038909,5/25/2015 15:43:02,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[PREVENTS],[PREVENTS],METHYLDOPA: double,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:43:52,1643039151,5/25/2015 15:43:25,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],Treatment HYPERTENSION pregnancy with METHYLDOPA:,NONE,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:43:58,1643039185,5/25/2015 15:43:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Treatment of HYPERTENSION with METHYLDOPA:,N/A,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540263,5/25/2015 15:44:33,1643039328,5/25/2015 15:44:02,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],Treatment with,N/a,13,44,-1,24,54,TWrex-cause,800850-FS1,Treatment of HYPERTENSION in pregnancy with METHYLDOPA: a randomized double blind study.,HYPERTENSION,METHYLDOPA
725540264,5/25/2015 15:13:38,1643030417,5/25/2015 15:13:14,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:15:59,1643030870,5/25/2015 15:15:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:21:58,1643032227,5/25/2015 15:21:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH,na,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:23:23,1643032787,5/25/2015 15:23:00,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],for,n/a,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:24:02,1643032992,5/25/2015 15:22:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],THERAPY for,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:24:14,1643033044,5/25/2015 15:22:49,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Withdrawal of,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:27:02,1643033805,5/25/2015 15:26:52,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:27:59,1643034027,5/25/2015 15:27:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients,n/a,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:29:13,1643034390,5/25/2015 15:28:31,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],THERAPY,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:31:25,1643035131,5/25/2015 15:31:10,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],for,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:31:25,1643035134,5/25/2015 15:31:09,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [TREATS] [NONE] [OTHER],"[TREATS]
[PREVENTS]
[OTHER]
[NONE]",N/A,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:32:52,1643035578,5/25/2015 15:31:55,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],for,-,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:33:06,1643035649,5/25/2015 15:32:24,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],Withdrawal of,n/a,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:33:35,1643035775,5/25/2015 15:31:14,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],Withdrawal of,n/a,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540264,5/25/2015 15:36:23,1643036674,5/25/2015 15:35:48,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[PREVENTS],[PREVENTS],FLUCONAZOLE SUPPRESSIVE THERAPY THRUSH,N/A,92,56,-1,97,87,TWrex-cause,800455-FS1,"Gripshover BM, Valdez H, Salata RA et al. Withdrawal of FLUCONAZOLE SUPPRESSIVE THERAPY for THRUSH in patients responding to combination antiviral therapy including protease inhibitors.",THRUSH,FLUCONAZOLE SUPPRESSIVE THERAPY
725540265,5/25/2015 17:05:17,1643060416,5/25/2015 17:04:59,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],as treatment of,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:14:20,1643064753,5/25/2015 17:13:43,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CAUSES] [CONTRAINDICATES] [SIDE_EFFECT] [NONE],"[CAUSES]
[CONTRAINDICATES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:15:42,1643065477,5/25/2015 17:15:29,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],as treatment of,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:15:44,1643065511,5/25/2015 17:15:28,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],treatment,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:17:28,1643066277,5/25/2015 17:17:10,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:30:36,1643072377,5/25/2015 17:30:14,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[MANIFESTATION] [IS_A] [OTHER] [NONE],"[MANIFESTATION]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:33:29,1643073591,5/25/2015 17:33:04,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",as treatment of,n/a,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:38:25,1643076257,5/25/2015 17:37:59,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:40:47,1643077667,5/25/2015 17:40:23,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],treatment,n/a,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:41:06,1643077841,5/25/2015 17:40:51,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:42:27,1643078585,5/25/2015 17:40:53,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS:,n/a,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:46:23,1643080735,5/25/2015 17:46:06,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],as treatment of MALIGNANT,n/a,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 17:49:25,1643082662,5/25/2015 17:49:08,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,[TREATS],[TREATS],treatment,n/a,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 18:08:07,1643093047,5/25/2015 18:06:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],as treatment of,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540265,5/25/2015 18:08:52,1643093652,5/25/2015 18:08:41,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],as treatment of,N/A,67,36,-1,91,50,TWrex-cause,803726-FS1,"Levy R, Shpitzer T, Shvero J et al. ORAL OFLOXACIN as treatment of MALIGNANT EXTERNAL OTITIS: a study of 17 cases.",MALIGNANT EXTERNAL OTITIS,ORAL OFLOXACIN
725540266,5/25/2015 15:15:42,1643030814,5/25/2015 15:13:39,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],of ACIDOSIS,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:16:31,1643030990,5/25/2015 15:16:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],correction,n/a,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:22:37,1643032504,5/25/2015 15:22:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Prevention of metabolic ACIDOSIS,na,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:23:40,1643032869,5/25/2015 15:23:25,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:25:08,1643033262,5/25/2015 15:24:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],correction of,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:25:13,1643033278,5/25/2015 15:24:40,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:27:18,1643033883,5/25/2015 15:27:05,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[PREVENTS],[PREVENTS],Prevention,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:28:25,1643034147,5/25/2015 15:28:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],TRIS BUFFER TRIS Uses Prevention and correction of metabolic ACIDOSIS,n/a,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:29:37,1643034531,5/25/2015 15:29:15,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:31:39,1643035243,5/25/2015 15:31:28,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [SYMPTOM] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]
[NONE]",N/A,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:32:12,1643035389,5/25/2015 15:31:26,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],Uses,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:33:10,1643035708,5/25/2015 15:32:54,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],Uses,-,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:34:01,1643035907,5/25/2015 15:33:07,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[PREVENTS],[PREVENTS],Prevention and correction of,n/a,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:34:58,1643036252,5/25/2015 15:33:39,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],Prevention and correction,n/a,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540266,5/25/2015 15:37:08,1643036826,5/25/2015 15:36:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],Prevention,N/A,175,69,-1,183,113,TWrex-cause,804784-FS1,"a ,   100  Class:  Alkalinizing Agents 40:08; TN900 (VA)  Synonyms:  TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE); Tham  Uses  Acidosis  Prevention and correction of metabolic ACIDOSIS associated with cardiac bypass surgery.",ACIDOSIS,TRIS BUFFER TRIS (HYDROXYMETHYLAMINOMETHANE)
725540267,5/25/2015 15:20:17,1643031768,5/25/2015 15:19:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],infection by,n/a,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:25:15,1643033280,5/25/2015 15:24:41,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],SPARGANOSIS represents infection by LARVAL TAPEWORMS,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:27:19,1643033886,5/25/2015 15:27:06,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],related,n/a,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:30:50,1643034976,5/25/2015 15:30:37,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],represents,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:30:54,1643034989,5/25/2015 15:30:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],SPARGANOSIS infection by LARVAL TAPEWORMS,na,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:34:02,1643035910,5/25/2015 15:33:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],SPARGANOSIS represents infection by LARVAL TAPEWORMS,n/a,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:35:08,1643036303,5/25/2015 15:34:56,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [SIDE_EFFECT] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:35:14,1643036310,5/25/2015 15:34:52,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],represents infection,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:36:12,1643036621,5/25/2015 15:35:17,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[CAUSES],[CAUSES],represents infection,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:38:23,1643037186,5/25/2015 15:38:08,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],represents,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:39:12,1643037430,5/25/2015 15:38:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],infection by,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:39:29,1643037543,5/25/2015 15:39:16,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],represents,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:40:35,1643037851,5/25/2015 15:40:20,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],SPARGANOSIS LARVAL TAPEWORMS Diphyllobothrium.,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:41:50,1643038340,5/25/2015 15:41:12,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",represents by,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540267,5/25/2015 15:42:04,1643038437,5/25/2015 15:41:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LARVAL TAPEWORMS,N/A,0,36,1,10,52,TWrex-cause,812045-FS1,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS
725540268,5/25/2015 15:57:40,1643042641,5/25/2015 15:57:27,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:11:56,1643045937,5/25/2015 16:11:42,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatment,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:14:03,1643046602,5/25/2015 16:13:41,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],LEVOTHYROXINE treatment of HYPOTHYROIDISM,n/a,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:16:19,1643047182,5/25/2015 16:15:40,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[SYMPTOM] [SIDE_EFFECT] [OTHER] [NONE],"[SYMPTOM]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:17:57,1643047701,5/25/2015 16:17:31,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:18:30,1643047862,5/25/2015 16:18:09,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in the treatment of,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:26:23,1643049591,5/25/2015 16:26:12,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:28:59,1643050131,5/25/2015 16:28:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:30:17,1643050426,5/25/2015 16:29:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,n/a,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:32:54,1643051050,5/25/2015 16:32:24,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],treatment,N/a,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:32:57,1643051053,5/25/2015 16:32:22,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],treatment of,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:40:00,1643052446,5/25/2015 16:39:20,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CAUSES] [SIDE_EFFECT] [NONE],"[CAUSES]
[SIDE_EFFECT]
[NONE]",N/A,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:40:19,1643052535,5/25/2015 16:39:52,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treatment of,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:49:30,1643054745,5/25/2015 16:49:05,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540268,5/25/2015 16:57:59,1643057361,5/25/2015 16:57:11,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,84,41,-1,97,54,TWrex-cause,800221-FS1,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE
725540269,5/25/2015 15:22:05,1643032279,5/25/2015 15:21:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:29:05,1643034349,5/25/2015 15:28:44,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[LOCATION],[LOCATION],to the,n/a,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:30:09,1643034721,5/25/2015 15:29:07,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],HYPERTENSION blocker LOSARTAN,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:32:22,1643035442,5/25/2015 15:32:10,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:34:51,1643036177,5/25/2015 15:34:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],HYPERTENSION BP.,na,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:36:24,1643036680,5/25/2015 15:36:03,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],HYPERTENSION diuretic calcium channel needed to control BP.,n/a,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:37:16,1643036871,5/25/2015 15:37:03,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[CONTRAINDICATES] [OTHER] [NONE],"[CONTRAINDICATES]
[OTHER]
[NONE]",N/A,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:38:11,1643037135,5/25/2015 15:37:40,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:40:40,1643037889,5/25/2015 15:40:18,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],and,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:41:19,1643038138,5/25/2015 15:40:52,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:41:56,1643038393,5/25/2015 15:40:58,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],as needed to control,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:42:58,1643038827,5/25/2015 15:42:40,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],ventricular additional diuretic calcium,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:44:00,1643039196,5/25/2015 15:43:24,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],with using,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:44:20,1643039297,5/25/2015 15:43:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],needed to control BP.,n/a,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540269,5/25/2015 15:46:27,1643039893,5/25/2015 15:46:09,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [ASSOCIATED_WITH] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,84,166,-1,95,174,TWrex-cause,804786-FS1,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN
725540270,5/25/2015 15:53:29,1643041829,5/25/2015 15:51:18,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PART_OF] [NONE],"[PART_OF]
[NONE]",N/A,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 15:53:49,1643041885,5/25/2015 15:53:40,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],paroxysmal,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 15:57:09,1643042560,5/25/2015 15:56:28,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],"randomized, controlled trial of",N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 15:57:17,1643042582,5/25/2015 15:56:20,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[NONE],[NONE],n/a,Propafenone just refers to part of the name of the study group that was done in the UK.,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 15:57:36,1643042628,5/25/2015 15:57:08,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PROPAFENONE PSVT,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 15:59:10,1643042974,5/25/2015 15:58:30,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[OTHER],[OTHER],trial PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT,NONE,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:08:09,1643044867,5/25/2015 16:07:35,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[OTHER],[OTHER],PROPAFENONE PSVT Study Group:,n/a,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:08:27,1643044937,5/25/2015 16:08:10,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[SYMPTOM],[SYMPTOM],paroxysmal,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:08:52,1643044981,5/25/2015 16:08:31,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[ASSOCIATED_WITH] [TREATS] [OTHER] [NONE],"[TREATS]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:10:44,1643045485,5/25/2015 16:09:56,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:14:46,1643046883,5/25/2015 16:14:15,false,clixsense,1.0,30544555,USA,TX,Mount Pleasant,70.196.7.174,[TREATS] [PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA fibrillation.UK PROPAFENONE Study Group:,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:14:55,1643046896,5/25/2015 16:14:40,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],fibrillation.UK,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:16:46,1643047280,5/25/2015 16:15:22,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"randomized, placebo controlled trial of in prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA PROPAFENONE",N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:17:12,1643047394,5/25/2015 16:16:13,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],controlled trial of,N/A,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540270,5/25/2015 16:17:19,1643047415,5/25/2015 16:16:01,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:",n/a,76,154,-1,114,165,TWrex-cause,804941-FS1,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE
725540271,5/25/2015 16:51:21,1643055356,5/25/2015 16:51:09,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[SIDE_EFFECT] [PART_OF] [OTHER] [NONE],"[SIDE_EFFECT]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:03:48,1643059693,5/25/2015 17:03:11,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],in,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:13:21,1643064332,5/25/2015 17:13:06,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[LOCATION] [ASSOCIATED_WITH] [IS_A] [PART_OF] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]
[NONE]",N/A,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:15:10,1643065175,5/25/2015 17:14:47,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],in,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:15:13,1643065178,5/25/2015 17:14:56,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in infants with,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:16:46,1643065918,5/25/2015 17:16:15,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],with,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:29:41,1643072019,5/25/2015 17:28:04,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT] [PART_OF] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:32:36,1643073219,5/25/2015 17:31:31,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],in preterm infants with,n/a,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:37:38,1643075825,5/25/2015 17:36:43,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],in preterm,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:39:25,1643076952,5/25/2015 17:38:01,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],INDOMETHACIN in preterm infants with PDA,n/a,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:39:46,1643077131,5/25/2015 17:38:57,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,n/a,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:40:05,1643077316,5/25/2015 17:39:45,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[PREVENTS],[PREVENTS],INDOMETHACIN,n/a,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:45:35,1643080188,5/25/2015 17:44:31,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],in preterm infants with PDA,n/a,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 17:48:40,1643082230,5/25/2015 17:48:00,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,[NONE],[NONE],n/a,might be treatment but unclear,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540271,5/25/2015 18:05:41,1643091668,5/25/2015 18:04:53,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],in preterm infants with,N/A,79,42,-1,81,54,TWrex-cause,800189-FS1,"Zarfin Y, Koren G, Perlman M. Digoxin and INDOMETHACIN in preterm infants with PDA",PDA,INDOMETHACIN
725540272,5/25/2015 16:31:50,1643050825,5/25/2015 16:31:38,false,elite,1,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],Treatment,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 16:48:13,1643054383,5/25/2015 16:48:00,false,elite,1,31526431,USA,CA,Elk Grove,67.166.135.122,[PREVENTS] [SYMPTOM] [ASSOCIATED_WITH] [NONE],"[PREVENTS]
[SYMPTOM]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:00:51,1643058436,5/25/2015 16:59:57,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],3 times weekly,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:11:45,1643063570,5/25/2015 17:11:31,false,elite,1,31868941,USA,CO,Englewood,63.228.91.212,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [IS_A] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[IS_A]
[NONE]",N/A,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:12:53,1643064094,5/25/2015 17:12:18,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation.,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:13:10,1643064231,5/25/2015 17:12:42,false,neodev,1,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],Treatment of,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:13:15,1643064250,5/25/2015 17:12:40,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment of,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:16:15,1643065686,5/25/2015 17:15:38,false,prodege,1,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],Treatment,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:25:44,1643070327,5/25/2015 17:25:26,false,elite,1,31869729,USA,CO,Pueblo,67.190.156.46,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [MANIFESTATION] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[MANIFESTATION]
[NONE]",N/A,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:27:20,1643071046,5/25/2015 17:26:33,false,neodev,1,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],Treatment of,n/a,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:28:03,1643071422,5/25/2015 17:27:16,false,elite,1,28624269,USA,NY,New York,198.199.80.197,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Treatment,n/a,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:31:43,1643072916,5/25/2015 17:30:49,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],Pediatric Patients Treatment of CHRONIC HEPATITIS B VIRUS &gt; INTERFERON ALFA 2B (Intron ® A),n/a,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:33:54,1643073881,5/25/2015 17:33:12,false,clixsense,1,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],Treatment of,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:34:19,1643074161,5/25/2015 17:33:51,false,neodev,1,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540272,5/25/2015 17:34:57,1643074505,5/25/2015 17:34:17,false,bitcoinget,1,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],Treatment,n/a,33,82,-1,73,100,TWrex-cause,800860-FS1,"Pediatric Patients  Treatment of CHRONIC HEPATITIS B VIRUS (HBV INFECTION)  >     INTERFERON ALFA 2B (Intron ®  A)  Sub Q:  Children ≥1 year of age: 3 million units/m 2  3 times weekly for the first week, then 6 million units/m 2  3 times weekly (maximum of 10 million units 3 times weekly.",CHRONIC HEPATITIS B VIRUS (HBV INFECTION),INTERFERON ALFA 2B
725540273,5/25/2015 15:43:08,1643038882,5/25/2015 15:42:56,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],comparison,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:45:50,1643039715,5/25/2015 15:45:31,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[MANIFESTATION],[MANIFESTATION],Suleman comparison fluconazole AMPHOTERICIN,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:46:07,1643039816,5/25/2015 15:45:44,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [ASSOCIATED_WITH] [OTHER] [NONE],"[CAUSES]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:46:30,1643039910,5/25/2015 15:46:00,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],anti fungal agents,n/a,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:46:34,1643039922,5/25/2015 15:45:43,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],as empiric anti fungal agents in,n/a,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:46:38,1643039935,5/25/2015 15:45:44,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],comparison of,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:46:44,1643039973,5/25/2015 15:46:21,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],anti fungal agents,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:47:09,1643040142,5/25/2015 15:46:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],comparison of as empiric anti fungal in patients with,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:47:11,1643040151,5/25/2015 15:46:33,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],as empiric anti fungal agents,n/a,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:47:25,1643040235,5/25/2015 15:45:57,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],comparison,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:47:26,1643040243,5/25/2015 15:46:36,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AMPHOTERICIN B empiric anti fungal agents cancer patients NEUTROPENIA,NONE,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:47:32,1643040272,5/25/2015 15:46:57,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],randomized with,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:54:16,1643041973,5/25/2015 15:52:55,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as empiric anti fungal agents in,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 15:56:56,1643042485,5/25/2015 15:56:24,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],AMPHOTERICIN B empiric anti fungal agents,n/a,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540273,5/25/2015 16:03:15,1643043837,5/25/2015 16:03:00,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[SYMPTOM],[SYMPTOM],prolonged,N/A,182,93,-1,192,107,TWrex-cause,800740-FS1,"1]  Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with AMPHOTERICIN B as empiric anti fungal agents in cancer patients with prolonged fever and NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B
725540274,5/25/2015 15:44:13,1643039287,5/25/2015 15:44:02,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:47:24,1643040248,5/25/2015 15:47:02,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],"disease, herpangina, ENTEROVIRUSES",N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:47:32,1643040266,5/25/2015 15:47:19,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CONTRAINDICATES] [IS_A] [NONE],"[CONTRAINDICATES]
[IS_A]
[NONE]",N/A,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:48:35,1643040584,5/25/2015 15:48:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],EPIDEMIC PLEURODYNIA,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:48:47,1643040604,5/25/2015 15:48:26,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:49:28,1643040802,5/25/2015 15:49:09,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],caused almost exclusively by,n/a,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:49:30,1643040807,5/25/2015 15:49:04,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CAUSES],[CAUSES],EPIDEMIC PLEURODYNIA caused exclusively by ENTEROVIRUSES,NONE,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:49:48,1643040870,5/25/2015 15:49:24,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],are caused by,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:50:25,1643041110,5/25/2015 15:50:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,n/a,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:52:31,1643041631,5/25/2015 15:52:06,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],are caused by,n/a,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 15:59:11,1643042995,5/25/2015 15:58:40,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CAUSES],[CAUSES],EPIDEMIC PLEURODYNIA are caused by ENTEROVIRUSES,n/a,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 16:01:55,1643043578,5/25/2015 16:01:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],are caused almost exclusively by,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 16:04:04,1643044085,5/25/2015 16:03:44,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[CAUSES],[CAUSES],caused,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 16:04:31,1643044141,5/25/2015 16:03:54,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],EPIDEMIC PLEURODYNIA caused by ENTEROVIRUSES,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540274,5/25/2015 16:04:42,1643044169,5/25/2015 16:04:00,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused almost exclusively by,N/A,0,113,1,19,126,TWrex-cause,810784-FS1,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES
725540275,5/25/2015 16:30:16,1643050431,5/25/2015 16:30:03,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],presence,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 16:46:50,1643054141,5/25/2015 16:46:28,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CONTRAINDICATES] [PART_OF] [NONE],"[CONTRAINDICATES]
[PART_OF]
[NONE]",N/A,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 16:56:41,1643056949,5/25/2015 16:55:07,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[MANIFESTATION],[MANIFESTATION],is the presence of,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:05:29,1643060473,5/25/2015 17:04:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]",presence of,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:10:09,1643062773,5/25/2015 17:09:42,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[IS_A] [MANIFESTATION],"[MANIFESTATION]
[IS_A]",is,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:10:09,1643062790,5/25/2015 17:09:58,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[LOCATION] [CONTRAINDICATES] [IS_A] [NONE],"[LOCATION]
[CONTRAINDICATES]
[IS_A]
[NONE]",N/A,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:10:15,1643062828,5/25/2015 17:09:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],presence in bloodstream.,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:10:41,1643062964,5/25/2015 17:10:22,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[CAUSES],[CAUSES],is the presence of,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:10:46,1643062999,5/25/2015 17:09:38,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[MANIFESTATION],[MANIFESTATION],presence,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:19:09,1643067103,5/25/2015 17:18:33,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is the presence of,n/a,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:23:24,1643069073,5/25/2015 17:21:55,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[MANIFESTATION],[MANIFESTATION],presence,n/a,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:23:34,1643069140,5/25/2015 17:23:11,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[SYMPTOM] [OTHER] [NONE],"[SYMPTOM]
[OTHER]
[NONE]",N/A,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:23:48,1643069272,5/25/2015 17:23:04,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A],[IS_A],BACTEREMIA is the presence of BACTERIA in bloodstream.,n/a,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:29:29,1643071950,5/25/2015 17:28:23,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[MANIFESTATION],[MANIFESTATION],presence,N/A,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540275,5/25/2015 17:30:19,1643072272,5/25/2015 17:28:36,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[SYMPTOM],[SYMPTOM],presence,n/a,0,30,1,9,38,TWrex-cause,812049-FS1,BACTEREMIA is the presence of BACTERIA in the bloodstream.,BACTEREMIA,BACTERIA
725540276,5/25/2015 15:56:26,1643042357,5/25/2015 15:55:51,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 15:58:09,1643042747,5/25/2015 15:57:51,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[MANIFESTATION] [SIDE_EFFECT] [OTHER] [NONE],"[MANIFESTATION]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:03:26,1643043883,5/25/2015 16:02:44,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[OTHER],[OTHER],"Clinical trials TYPE 2 DIABETES lasted month, compared METFORMIN",NONE,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:10:38,1643045441,5/25/2015 16:10:26,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:12:01,1643045959,5/25/2015 16:11:38,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],TYPE 2 DIABETES METFORMIN treatments,n/a,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:13:01,1643046246,5/25/2015 16:12:41,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[OTHER] [PART_OF] [ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:15:11,1643046926,5/25/2015 16:14:20,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],or combined with other treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:16:31,1643047206,5/25/2015 16:16:20,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:22:03,1643048578,5/25/2015 16:21:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:24:49,1643049285,5/25/2015 16:24:35,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],"therapy,",N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:25:21,1643049376,5/25/2015 16:23:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"STUDY SELECTION Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",n/a,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:27:30,1643049745,5/25/2015 16:25:55,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:28:32,1643050082,5/25/2015 16:27:56,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],treatments,N/A,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:30:18,1643050433,5/25/2015 16:29:57,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[TREATS],[TREATS],treatments,N/a,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540276,5/25/2015 16:37:33,1643051820,5/25/2015 16:36:34,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],treatments,n/a,97,140,-1,111,149,TWrex-cause,800103-FS1,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN
725540277,5/25/2015 17:14:54,1643065051,5/25/2015 17:14:22,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [ASSOCIATED_WITH] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:15:56,1643065566,5/25/2015 17:15:43,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],caused by,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:16:09,1643065628,5/25/2015 17:15:46,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[CAUSES],[CAUSES],caused by,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:17:57,1643066584,5/25/2015 17:17:30,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:30:55,1643072483,5/25/2015 17:30:43,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [CONTRAINDICATES] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:33:49,1643073790,5/25/2015 17:33:29,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],caused by,n/a,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:38:44,1643076530,5/25/2015 17:38:26,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:41:33,1643078203,5/25/2015 17:40:51,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[CAUSES],[CAUSES],caused,n/a,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:41:35,1643078218,5/25/2015 17:41:10,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],of,n/a,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:43:14,1643079032,5/25/2015 17:42:32,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[CAUSES],[CAUSES],GRANULOMA INGUINALE is a progressive infection caused by CALYMMATOBACTERIUM GRANULOMATIS,n/a,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:46:48,1643081023,5/25/2015 17:46:24,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],caused by CALYMMATOBACTERIUM,n/a,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 17:49:57,1643082953,5/25/2015 17:49:32,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,[CAUSES],[CAUSES],caused,n/a,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 18:08:47,1643093608,5/25/2015 18:08:11,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 18:09:25,1643094003,5/25/2015 18:08:54,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,[CAUSES],[CAUSES],caused by,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540277,5/25/2015 18:10:41,1643094914,5/25/2015 18:09:50,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,0,110,1,18,141,TWrex-cause,810025-FS1,GRANULOMA INGUINALE  (Donovanosis)  GRANULOMA INGUINALE is a progressive infection of genital skin caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
725540278,5/25/2015 15:54:35,1643042033,5/25/2015 15:54:22,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 15:56:55,1643042481,5/25/2015 15:56:41,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[MANIFESTATION] [IS_A] [OTHER] [NONE],"[MANIFESTATION]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 15:58:22,1643042809,5/25/2015 15:58:09,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],as primary therapy for,n/a,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 15:58:39,1643042875,5/25/2015 15:58:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:00:27,1643043341,5/25/2015 16:00:03,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],CHLORAMBUCIL as primary therapy CHRONIC LYMPHOCYTIC LEUKEMIA,NONE,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:09:19,1643045121,5/25/2015 16:09:05,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],therapy,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:09:56,1643045260,5/25/2015 16:09:23,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],CHLORAMBUCIL primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA,n/a,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:11:43,1643045857,5/25/2015 16:11:05,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[MANIFESTATION] [SIDE_EFFECT] [OTHER] [NONE],"[MANIFESTATION]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:11:48,1643045869,5/25/2015 16:11:27,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as primary therapy for,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:15:35,1643046987,5/25/2015 16:15:24,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],therapy,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:18:26,1643047856,5/25/2015 16:18:19,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:18:58,1643047934,5/25/2015 16:18:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],therapy for,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:19:22,1643048016,5/25/2015 16:18:37,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],CHLORAMBUCIL as therapy for CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:20:14,1643048186,5/25/2015 16:18:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA,n/a,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540278,5/25/2015 16:24:05,1643049097,5/25/2015 16:23:52,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],therapy,N/A,139,103,-1,166,115,TWrex-cause,803854-FS1,"1]  Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL
725540279,5/25/2015 15:22:56,1643032603,5/25/2015 15:22:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],"mg/d, for PANIC DISORDER",n/a,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:31:28,1643035142,5/25/2015 15:30:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],treated with PAROXETINE for PANIC DISORDER,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:33:06,1643035646,5/25/2015 15:32:53,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treated,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:36:10,1643036583,5/25/2015 15:35:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PAROXETINE for PANIC DISORDER,na,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:37:20,1643036904,5/25/2015 15:37:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],patients treated with PAROXETINE for PANIC DISORDER,n/a,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:38:36,1643037273,5/25/2015 15:38:23,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [ASSOCIATED_WITH] [SIDE_EFFECT] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:40:26,1643037804,5/25/2015 15:39:07,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:41:16,1643038103,5/25/2015 15:41:05,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],for,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:42:01,1643038433,5/25/2015 15:41:50,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treated,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:44:01,1643039201,5/25/2015 15:43:46,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PAROXETINE PANIC DISORDER,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:44:24,1643039305,5/25/2015 15:43:13,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],were not associated with,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:44:39,1643039355,5/25/2015 15:44:23,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treated with,n/a,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:44:57,1643039412,5/25/2015 15:44:27,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],treated with PAROXETINE for PANIC DISORDER,NONE,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:45:00,1643039433,5/25/2015 15:44:36,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PAROXETINE,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540279,5/25/2015 15:45:14,1643039493,5/25/2015 15:44:36,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treated with,N/A,59,35,-1,72,45,TWrex-cause,800469-FS1,"• A study of patients treated with PAROXETINE 10 mg/d, for PANIC DISORDER reported higher plasma drug concentrations were not associated with improved benefit ( 92.",PANIC DISORDER,PAROXETINE
725540280,5/25/2015 16:31:04,1643050637,5/25/2015 16:30:51,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 16:47:45,1643054308,5/25/2015 16:47:28,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[PREVENTS] [LOCATION] [ASSOCIATED_WITH] [NONE],"[PREVENTS]
[LOCATION]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 16:59:26,1643057896,5/25/2015 16:58:33,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],treatment of,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:07:43,1643061592,5/25/2015 17:07:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:10:57,1643063134,5/25/2015 17:10:45,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CAUSES] [MANIFESTATION] [SIDE_EFFECT] [NONE],"[CAUSES]
[MANIFESTATION]
[SIDE_EFFECT]
[NONE]",N/A,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:11:49,1643063596,5/25/2015 17:11:25,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],treatment of children with,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:11:53,1643063619,5/25/2015 17:11:32,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:12:19,1643063809,5/25/2015 17:11:36,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],treatment,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:14:20,1643064757,5/25/2015 17:13:19,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],treatment,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:22:41,1643068715,5/25/2015 17:21:54,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],treatment of children and adolescents with,n/a,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:24:30,1643069630,5/25/2015 17:24:13,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[OTHER]
[NONE]",N/A,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:26:25,1643070647,5/25/2015 17:25:18,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[OTHER],[OTHER],and,n/a,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:29:03,1643071767,5/25/2015 17:27:32,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[PREVENTS],[PREVENTS],alZIPRASIDONE treatment of children with TOURETTE'S SYNDROME:,n/a,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:32:14,1643073067,5/25/2015 17:31:32,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],treatment of,N/A,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540280,5/25/2015 17:33:10,1643073485,5/25/2015 17:32:44,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],treatment,n/a,90,35,-1,108,46,TWrex-cause,800745-FS1,"Sallee FR, Kurlan R, Goetz CG et alZIPRASIDONE treatment of children and adolescents with TOURETTE'S SYNDROME: a pilot study.",TOURETTE'S SYNDROME,ZIPRASIDONE
725540281,5/25/2015 15:57:11,1643042561,5/25/2015 15:56:57,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],concentrating,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 15:59:06,1643042959,5/25/2015 15:58:53,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [PART_OF] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:11:23,1643045694,5/25/2015 16:11:12,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:13:22,1643046390,5/25/2015 16:12:43,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],GITELMAN SYNDROME can demonstrate HYPOCALCIURIA,n/a,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:15:23,1643046946,5/25/2015 16:15:15,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[SIDE_EFFECT] [PART_OF] [NONE],"[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:17:16,1643047398,5/25/2015 16:17:01,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:17:39,1643047562,5/25/2015 16:16:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],and have,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:25:55,1643049516,5/25/2015 16:25:42,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],interstitial,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:27:29,1643049740,5/25/2015 16:25:09,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can demonstrate,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:28:34,1643050095,5/25/2015 16:27:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER] [IS_A],"[IS_A]
[OTHER]","In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",n/a,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:31:13,1643050657,5/25/2015 16:29:07,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and have,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:31:40,1643050742,5/25/2015 16:31:17,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[MANIFESTATION],[MANIFESTATION],can demonstrate,N/a,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:32:57,1643051052,5/25/2015 16:31:09,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and have,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:38:49,1643052177,5/25/2015 16:38:32,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[LOCATION] [ASSOCIATED_WITH] [PART_OF] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540281,5/25/2015 16:42:36,1643053125,5/25/2015 16:41:41,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],demonstrate normal,N/A,291,211,1,303,228,TWrex-cause,812847-FS1,"In contrast to patients with Bartter syndrome, who have a defect in urinary concentrating ability (normal function of the loop of Henle is needed to generate a high interstitial osmotic gradient), patients with GITELMAN SYNDROME can demonstrate normal urinary concentrating ability and have HYPOCALCIURIA",HYPOCALCIURIA,GITELMAN SYNDROME
725540282,5/25/2015 15:54:05,1643041943,5/25/2015 15:53:54,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],moderately,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 15:55:20,1643042209,5/25/2015 15:53:32,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[TREATS] [ASSOCIATED_WITH] [OTHER] [NONE],"[TREATS]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 15:57:45,1643042665,5/25/2015 15:57:19,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],for mild moderately active,n/a,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 15:57:44,1643042666,5/25/2015 15:57:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",response trial of,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 15:58:00,1643042719,5/25/2015 15:57:38,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ULCERATIVE COLITIS,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 15:59:41,1643043153,5/25/2015 15:59:12,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],trial of (MESALAMINE) for mild active ULCERATIVE COLITIS,NONE,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:08:45,1643044961,5/25/2015 16:08:31,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[LOCATION],[LOCATION],center,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:09:00,1643045013,5/25/2015 16:08:10,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],(MESALAMINE) for ULCERATIVE COLITIS,n/a,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:10:36,1643045423,5/25/2015 16:08:54,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF] [OTHER] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:11:03,1643045569,5/25/2015 16:10:46,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:15:09,1643046912,5/25/2015 16:14:56,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],double,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:17:43,1643047603,5/25/2015 16:17:13,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],trial of,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:17:53,1643047692,5/25/2015 16:16:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],multi center double blind dose response trial of (MESALAMINE) for ULCERATIVE COLITIS,N/A,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:18:17,1643047811,5/25/2015 16:18:03,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],response trial,n/a,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540282,5/25/2015 16:18:15,1643047813,5/25/2015 16:17:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],A multi center double blind dose response trial of Colazide (balsalazide disodium) and Asacol (MESALAMINE) for mild moderately active ULCERATIVE COLITIS,n/a,175,136,-1,192,146,TWrex-cause,800903-FS1,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide ®  (balsalazide disodium) and Asacol ®  (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE
725540283,5/25/2015 15:18:54,1643031447,5/25/2015 15:18:44,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:21:36,1643032143,5/25/2015 15:21:09,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:26:06,1643033501,5/25/2015 15:25:53,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],therapy,n/a,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:28:52,1643034266,5/25/2015 15:27:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS,na,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:29:48,1643034608,5/25/2015 15:29:36,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:31:50,1643035337,5/25/2015 15:30:07,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Maintenance,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:31:57,1643035345,5/25/2015 15:31:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS,n/a,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:33:25,1643035757,5/25/2015 15:33:00,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:34:03,1643035914,5/25/2015 15:33:51,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [CAUSES] [CONTRAINDICATES] [NONE],"[PREVENTS]
[CAUSES]
[CONTRAINDICATES]
[NONE]",N/A,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:34:37,1643036122,5/25/2015 15:33:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy for,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:36:34,1643036702,5/25/2015 15:36:20,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],therapy,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:38:24,1643037188,5/25/2015 15:38:11,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:39:24,1643037517,5/25/2015 15:39:08,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],Martens Danna FLUCONAZOLE RECURRENT VULVOVAGINAL,N/A,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:40:12,1643037740,5/25/2015 15:39:51,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy for,n/a,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540283,5/25/2015 15:40:28,1643037803,5/25/2015 15:40:08,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],therapy for,n/a,114,90,-1,147,101,TWrex-cause,803460-FS1,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE
725540284,5/25/2015 15:08:36,1643029327,5/25/2015 15:07:45,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.136,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",treatment,N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:10:51,1643029786,5/25/2015 15:10:13,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[MANIFESTATION],[MANIFESTATION],"HD patients, CHOREA becomes severe",N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:14:40,1643030622,5/25/2015 15:14:16,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],becomes severe,n/a,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:18:56,1643031461,5/25/2015 15:17:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],"In patients, the CHOREA becomes severe",N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:19:51,1643031627,5/25/2015 15:19:26,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],"In HD patients, CHOREA",na,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:19:55,1643031635,5/25/2015 15:18:59,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],treatment is appropriate.,N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:21:51,1643032197,5/25/2015 15:21:32,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],In,http://www.expedia.com/Abu-Dhabi-Emirate-Hotels-Howard-Johnson-Hotel-Diplomat-Abu-Dhabi-AE.h533280.Hotel-Information,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:25:51,1643033431,5/25/2015 15:25:34,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:26:14,1643033538,5/25/2015 15:25:58,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"In HD patients, the CHOREA becomes severe",n./a,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:27:18,1643033884,5/25/2015 15:26:57,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],becomes severe,N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:27:27,1643033944,5/25/2015 15:25:26,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"In some HD patients,",n/a,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:28:28,1643034173,5/25/2015 15:27:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"In some patients,",n/a,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:29:01,1643034298,5/25/2015 15:28:28,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],In,N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:30:12,1643034726,5/25/2015 15:29:53,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS] [TREATS] [NONE],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540284,5/25/2015 15:30:44,1643034944,5/25/2015 15:30:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],the becomes severe,n/a,25,8,1,30,10,TWrex-cause,812691-FS1,"In some HD patients, the CHOREA becomes severe and impairs function; in those instances, treatment is appropriate.",CHOREA,HD
725540285,5/25/2015 16:20:30,1643048227,5/25/2015 16:20:16,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 16:28:50,1643050112,5/25/2015 16:28:39,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],lymphomas,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 16:42:41,1643053191,5/25/2015 16:41:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA,n/a,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 16:43:51,1643053517,5/25/2015 16:43:36,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CONTRAINDICATES] [IS_A] [OTHER] [NONE],"[CONTRAINDICATES]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 16:46:24,1643054033,5/25/2015 16:45:37,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],new drug for,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 16:50:15,1643055006,5/25/2015 16:49:27,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],active new drug for,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:01:59,1643058964,5/25/2015 17:01:42,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],active new drug,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:03:58,1643059745,5/25/2015 17:03:25,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],active new drug for,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:05:58,1643060706,5/25/2015 17:05:15,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],active new drug,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:07:04,1643061275,5/25/2015 17:06:38,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],drug for,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:07:11,1643061312,5/25/2015 17:06:52,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",N/A,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:07:35,1643061523,5/25/2015 17:07:12,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],for,N/A,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:11:16,1643063272,5/25/2015 17:11:04,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.248.31,[NONE],[NONE],no,no,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:12:24,1643063831,5/25/2015 17:11:51,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],an active new drug for,n/a,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540285,5/25/2015 17:14:12,1643064701,5/25/2015 17:13:10,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,n/a,107,44,-1,125,59,TWrex-cause,804277-FS1,"O'Dwyer PJ, Cheson BD, Leyland Jones B et alDEOXYCOFORMYCIN: an active new drug for indolent lymphomas and HAIRY CELL LEUKEMIA",HAIRY CELL LEUKEMIA,DEOXYCOFORMYCIN
725540286,5/25/2015 17:04:57,1643060246,5/25/2015 17:03:50,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],treatment of,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:13:40,1643064477,5/25/2015 17:13:27,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [SIDE_EFFECT] [PART_OF] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:15:27,1643065318,5/25/2015 17:15:13,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],treatment,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:15:28,1643065336,5/25/2015 17:15:14,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in the treatment,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:17:07,1643066129,5/25/2015 17:16:49,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:30:04,1643072183,5/25/2015 17:29:50,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[MANIFESTATION] [PART_OF] [NONE],"[MANIFESTATION]
[PART_OF]
[NONE]",N/A,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:33:02,1643073423,5/25/2015 17:32:37,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",the treatment of,n/a,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:37:56,1643075971,5/25/2015 17:37:39,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:40:20,1643077425,5/25/2015 17:39:48,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],treatment,n/a,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:40:48,1643077678,5/25/2015 17:40:07,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:40:50,1643077689,5/25/2015 17:39:26,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER:,n/a,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:46:05,1643080531,5/25/2015 17:45:36,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],in the treatment of OBSESSIVE,n/a,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 17:49:03,1643082439,5/25/2015 17:48:44,false,instagc,1.0,20845955,GBR,I2,Manchester,90.214.24.62,[TREATS],[TREATS],treatment,n/a,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 18:06:13,1643091913,5/25/2015 18:05:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540286,5/25/2015 18:08:39,1643093500,5/25/2015 18:08:18,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],in the treatment of,N/A,68,37,-1,96,47,TWrex-cause,800351-FS1,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM
725540287,5/25/2015 15:49:33,1643040815,5/25/2015 15:49:12,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[PART_OF] [SIDE_EFFECT] [CONTRAINDICATES] [MANIFESTATION] [NONE],"[MANIFESTATION]
[CONTRAINDICATES]
[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 15:52:11,1643041543,5/25/2015 15:51:50,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 15:52:16,1643041576,5/25/2015 15:50:31,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PROCAINAMIDE,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 15:53:45,1643041882,5/25/2015 15:53:19,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 15:54:03,1643041936,5/25/2015 15:53:45,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],for the acute treatment of,n/a,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 15:54:09,1643041946,5/25/2015 15:53:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],acute treatment of,n/a,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 15:56:11,1643042308,5/25/2015 15:55:44,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],PROCAINAMIDE acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,NONE,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:00:38,1643043353,5/25/2015 15:59:24,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment of,n/a,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:03:36,1643043918,5/25/2015 16:02:54,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],PROCAINAMIDE for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,n/a,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:06:47,1643044525,5/25/2015 16:06:30,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treatment,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:07:14,1643044606,5/25/2015 16:07:01,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[LOCATION] [ASSOCIATED_WITH] [OTHER] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:07:30,1643044703,5/25/2015 16:07:09,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the acute treatment of,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:10:13,1643045327,5/25/2015 16:09:41,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],PROCAINAMIDE treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:11:31,1643045790,5/25/2015 16:10:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",n/a,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540287,5/25/2015 16:11:42,1643045843,5/25/2015 16:10:07,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,110,61,-1,156,73,TWrex-cause,804433-FS1,"Alternative to other antiarrhythmic drugs (e.g., amiodarone, PROCAINAMIDE sotalol) for the acute treatment of HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY (e.g., VPCs) that occurs following myocardial ischemia or infarction or during cardiac manipulative procedures such as cardiac surgery or cardiac catheterization.",HEMODYNAMICALLY COMPROMISING VENTRICULAR ECTOPY,PROCAINAMIDE
725540288,5/25/2015 15:23:39,1643032864,5/25/2015 15:23:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],elective repair,n/a,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:33:40,1643035796,5/25/2015 15:32:27,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],repair of ASCENDING AORTIC ANEURYSM in patient with MARFAN SYNDROME,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:34:13,1643035951,5/25/2015 15:33:49,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],repair,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:38:25,1643037198,5/25/2015 15:37:58,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME,n/a,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:38:43,1643037289,5/25/2015 15:38:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],ASCENDING AORTIC ANEURYSM in patient with MARFAN SYNDROME,na,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:39:31,1643037559,5/25/2015 15:39:14,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[CAUSES] [IS_A] [NONE],"[CAUSES]
[IS_A]
[NONE]",N/A,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:42:03,1643038436,5/25/2015 15:41:34,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:42:21,1643038576,5/25/2015 15:42:04,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],with,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:42:53,1643038799,5/25/2015 15:42:33,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],elective,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:45:21,1643039555,5/25/2015 15:44:51,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],repair ASCENDING ANEURYSM patient MARFAN,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:45:41,1643039685,5/25/2015 15:45:29,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:45:58,1643039747,5/25/2015 15:45:37,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],in a patient with,n/a,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:46:20,1643039867,5/25/2015 15:45:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ASCENDING AORTIC ANEURYSM,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:46:33,1643039920,5/25/2015 15:45:28,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],elective repair ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME,NONE,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540288,5/25/2015 15:46:55,1643040017,5/25/2015 15:45:25,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SIDE_EFFECT],[SIDE_EFFECT],with,N/A,69,113,1,93,128,TWrex-cause,813266-FS1,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME
725540289,5/25/2015 15:43:24,1643038920,5/25/2015 15:43:10,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],symptoms,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:46:11,1643039832,5/25/2015 15:45:54,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],MIGRAINE from HEADACHE with neurologic,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:46:44,1643039974,5/25/2015 15:46:29,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [ASSOCIATED_WITH] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:47:11,1643040149,5/25/2015 15:46:45,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],MIGRAINE,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:47:45,1643040307,5/25/2015 15:47:29,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],symptoms,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:47:47,1643040316,5/25/2015 15:46:31,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],other types,n/a,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:47:50,1643040337,5/25/2015 15:47:28,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[SIDE_EFFECT],[SIDE_EFFECT],MIGRAINE tension type HEADACHE,NONE,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:47:57,1643040382,5/25/2015 15:47:13,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[IS_A],[IS_A],types of,n/a,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:48:03,1643040408,5/25/2015 15:47:34,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],Evaluate symptoms to,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:48:12,1643040456,5/25/2015 15:46:36,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],or other types of,n/a,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:48:16,1643040482,5/25/2015 15:47:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],or other types of,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:54:44,1643042048,5/25/2015 15:54:21,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],Evaluate symptoms,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:57:24,1643042591,5/25/2015 15:56:57,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[IS_A],[IS_A],MIGRAINE from tension type other types HEADACHE,n/a,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 15:59:04,1643042940,5/25/2015 15:58:20,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE,n/a,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540289,5/25/2015 16:02:55,1643043799,5/25/2015 16:01:21,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[SYMPTOM],[SYMPTOM],symptoms,N/A,82,37,1,89,45,TWrex-cause,814476-FS1,3.2 Evaluate symptoms to distinguish MIGRAINE from tension type or other types of HEADACHE in patients with a normal neurologic exam.,HEADACHE,MIGRAINE
725540290,5/25/2015 15:17:35,1643031187,5/25/2015 15:17:16,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:18:22,1643031326,5/25/2015 15:17:32,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],"SYSTEMIC INFECTION: therapy with PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE",N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:24:36,1643033075,5/25/2015 15:23:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],"SYSTEMIC INFECTION: therapy is required, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE",na,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:24:55,1643033154,5/25/2015 15:24:36,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:27:22,1643033885,5/25/2015 15:26:47,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],"is required,",N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:28:06,1643034046,5/25/2015 15:27:49,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:28:33,1643034181,5/25/2015 15:27:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy with,N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:29:42,1643034583,5/25/2015 15:29:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],SYSTEMIC INFECTION: therapy with an anti PSEUDOMONAL CEPHALOSPORIN,n/a,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:31:16,1643035109,5/25/2015 15:30:54,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:32:33,1643035512,5/25/2015 15:32:20,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [ASSOCIATED_WITH] [IS_A] [NONE],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[NONE]",N/A,N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:34:07,1643035934,5/25/2015 15:33:54,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],therapy,-,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:34:12,1643035949,5/25/2015 15:33:43,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],therapy,N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:36:37,1643036713,5/25/2015 15:36:23,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:37:18,1643036895,5/25/2015 15:36:54,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],"SYSTEMIC INFECTION: PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE",N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540290,5/25/2015 15:39:51,1643037612,5/25/2015 15:37:37,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],"therapy is required, with",N/A,0,125,-1,17,179,TWrex-cause,804796-FS1,"SYSTEMIC INFECTION:  Parenteral therapy is required, generally with an aminoglycoside plus an antipseudomonal β lactam, anti PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME. CEFOPERAZONE or meropenem.",SYSTEMIC INFECTION,"PSEUDOMONAL CEPHALOSPORIN (EG), CEFEPIME, CEFOPERAZONE"
725540291,5/25/2015 15:18:27,1643031329,5/25/2015 15:18:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],increased risk,n/a,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:20:10,1643031711,5/25/2015 15:19:18,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:25:37,1643033389,5/25/2015 15:25:24,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[MANIFESTATION],[MANIFESTATION],manifestations,n/a,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:26:53,1643033766,5/25/2015 15:26:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS,na,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:28:57,1643034287,5/25/2015 15:28:43,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[LOCATION],[LOCATION],parkinsonian,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:29:22,1643034435,5/25/2015 15:28:48,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[MANIFESTATION],[MANIFESTATION],manifestations of,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:30:58,1643035008,5/25/2015 15:30:30,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SIDE_EFFECT],[SIDE_EFFECT],risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS,n/a,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:32:12,1643035378,5/25/2015 15:30:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and increased sensitivity to ANTIPSYCHOTIC AGENTS,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:32:30,1643035482,5/25/2015 15:32:07,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:33:18,1643035740,5/25/2015 15:33:04,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [PART_OF] [SIDE_EFFECT] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[SIDE_EFFECT]
[PART_OF]
[NONE]",N/A,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:35:38,1643036407,5/25/2015 15:35:19,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:37:47,1643037002,5/25/2015 15:37:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],manifestations,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:38:40,1643037282,5/25/2015 15:38:18,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],ANTIPSYCHOTIC AGENTS,N/A,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:40:07,1643037711,5/25/2015 15:38:51,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[MANIFESTATION],[MANIFESTATION],Possible increased risk of NMS and increased sensitivity to,n/a,36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540291,5/25/2015 15:41:02,1643038038,5/25/2015 15:38:57,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"They are, as far as I can tell, both two symptoms of something else. Not related to each other",36,69,1,38,89,TWrex-cause,812299-FS1,"a ,   b  Possible increased risk of NMS and increased sensitivity to ANTIPSYCHOTIC AGENTS in patients with parkinsonian syndrome or dementia with Lewy bodies; manifestations of sensitivity may include confusion, obtundation, postural instability with more frequent falling, or extrapyramidal adverse effects  104 ,   a ,   b  Patients with recent history of MI or unstable heart disease generally were excluded from premarketing clinical studies.",NMS,ANTIPSYCHOTIC AGENTS
725540292,5/25/2015 15:54:20,1643042006,5/25/2015 15:54:07,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 15:56:39,1643042447,5/25/2015 15:56:26,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[ASSOCIATED_WITH] [OTHER] [NONE],"[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 15:58:08,1643042744,5/25/2015 15:57:46,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 15:58:15,1643042762,5/25/2015 15:57:47,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 15:58:17,1643042777,5/25/2015 15:58:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ENDOMETRIOSIS,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:00:01,1643043293,5/25/2015 15:59:42,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAIN associated with ENDOMETRIOSIS,NONE,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:09:01,1643045015,5/25/2015 16:08:47,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:09:22,1643045134,5/25/2015 16:09:01,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAIN associated with ENDOMETRIOSIS,n/a,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:11:03,1643045567,5/25/2015 16:10:51,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]
[NONE]",N/A,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:11:25,1643045713,5/25/2015 16:11:05,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:15:22,1643046941,5/25/2015 16:15:11,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:18:02,1643047748,5/25/2015 16:17:50,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],associated,n/a,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:18:37,1643047864,5/25/2015 16:17:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:18:36,1643047866,5/25/2015 16:17:54,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",PAIN associated with ENDOMETRIOSIS,N/A,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540292,5/25/2015 16:18:58,1643047933,5/25/2015 16:18:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,n/a,52,73,1,55,86,TWrex-cause,813422-FS1,2000 04 01  Modern combined oral contraceptives for PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
725540293,5/25/2015 15:20:37,1643031889,5/25/2015 15:20:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],received,n/a,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:26:20,1643033570,5/25/2015 15:25:16,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],BIPOLAR DISORDER who received LAMOTRIGINE,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:27:35,1643033976,5/25/2015 15:27:20,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:31:06,1643035048,5/25/2015 15:30:53,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[LOCATION],[LOCATION],failure,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:31:27,1643035144,5/25/2015 15:30:57,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],adults with BIPOLAR DISORDER who received LAMOTRIGINE,na,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:34:17,1643035980,5/25/2015 15:34:06,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],BIPOLAR DISORDER who received LAMOTRIGINE,n/a,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:35:24,1643036340,5/25/2015 15:35:10,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[LOCATION] [ASSOCIATED_WITH] [PART_OF] [NONE],"[LOCATION]
[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:35:36,1643036368,5/25/2015 15:35:15,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:36:57,1643036811,5/25/2015 15:36:19,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:38:42,1643037287,5/25/2015 15:38:24,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],received,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:39:48,1643037596,5/25/2015 15:39:31,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:40:18,1643037754,5/25/2015 15:39:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],who received,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:40:53,1643037962,5/25/2015 15:40:39,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[MANIFESTATION],[MANIFESTATION],"respectively, BIPOLAR DISORDER",N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:42:17,1643038544,5/25/2015 15:41:52,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540293,5/25/2015 15:42:35,1643038669,5/25/2015 15:42:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],who received,n/a,269,299,-1,284,310,TWrex-cause,800992-FS1,"1 ,   2 ,   6 ,   13 ,   22 ,   24  Fatalities associated with multiorgan failure and various degrees of hepatic failure have been reported in 0.05 or 0.16% of adults or children with seizure disorders who received lamotrigine, respectively,  1   and in no adults with BIPOLAR DISORDER who received LAMOTRIGINE",BIPOLAR DISORDER,LAMOTRIGINE
725540294,5/25/2015 15:44:00,1643039195,5/25/2015 15:43:44,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treat,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:46:57,1643040035,5/25/2015 15:46:42,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[PREVENTS],[PREVENTS],PRAZIQUANTEL ACUTE SCHISTOSOMIASIS,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:47:17,1643040184,5/25/2015 15:46:59,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[LOCATION] [MANIFESTATION] [ASSOCIATED_WITH] [NONE],"[LOCATION]
[MANIFESTATION]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:48:12,1643040455,5/25/2015 15:47:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PRAZIQUANTEL,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:48:23,1643040516,5/25/2015 15:48:07,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],Treatment,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:49:03,1643040667,5/25/2015 15:48:42,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],Treatment PRAZIQUANTEL has proven effectively treat ACUTE SCHISTOSOMIASIS,NONE,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:49:07,1643040674,5/25/2015 15:48:53,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],Treatment,n/a,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:49:22,1643040765,5/25/2015 15:49:00,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],Treatment with,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:50:03,1643040958,5/25/2015 15:48:56,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Treatment with,n/a,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:51:52,1643041457,5/25/2015 15:49:49,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],Treatment with,n/a,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 15:58:39,1643042874,5/25/2015 15:58:04,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CONTRAINDICATES] [TREATS],"[TREATS]
[CONTRAINDICATES]",Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS,n/a,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 16:01:28,1643043500,5/25/2015 16:01:09,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment with,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 16:03:39,1643043932,5/25/2015 16:03:17,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[TREATS],[TREATS],treat,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 16:03:52,1643044028,5/25/2015 16:03:27,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],Treatment with PRAZIQUANTEL effectively treat ACUTE SCHISTOSOMIASIS,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540294,5/25/2015 16:05:15,1643044229,5/25/2015 16:03:35,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[PREVENTS] [OTHER] [NONE],"[PREVENTS]
[OTHER]
[NONE]",N/A,N/A,71,17,-1,91,29,TWrex-cause,800597-FS1,• Treatment with PRAZIQUANTEL has not been proven to effectively treat ACUTE SCHISTOSOMIASIS but should be given together with oral corticosteroids.,ACUTE SCHISTOSOMIASIS,PRAZIQUANTEL
725540295,5/25/2015 15:23:23,1643032786,5/25/2015 15:23:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:32:26,1643035452,5/25/2015 15:32:04,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION);,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:33:45,1643035825,5/25/2015 15:33:33,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:37:56,1643037040,5/25/2015 15:37:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],WARTS are caused by HUMAN PAPILLOMAVIRUS,n/a,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:38:07,1643037120,5/25/2015 15:36:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],WARTS caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION);,na,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:39:09,1643037404,5/25/2015 15:38:55,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [MANIFESTATION] [IS_A] [OTHER] [NONE],"[PREVENTS]
[MANIFESTATION]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:41:32,1643038214,5/25/2015 15:40:58,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:42:02,1643038439,5/25/2015 15:41:49,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],caused,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:42:30,1643038586,5/25/2015 15:42:18,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:44:43,1643039369,5/25/2015 15:44:28,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[PREVENTS],[PREVENTS],HUMAN PAPILLOMAVIRUS INFECTION); are,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:45:19,1643039528,5/25/2015 15:45:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],WARTS,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:45:23,1643039561,5/25/2015 15:45:01,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[CAUSES],[CAUSES],WARTS caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION);,NONE,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:45:34,1643039608,5/25/2015 15:45:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused by,n/a,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:45:36,1643039644,5/25/2015 15:45:08,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[CAUSES],[CAUSES],caused by,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540295,5/25/2015 15:45:59,1643039769,5/25/2015 15:45:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,0,20,1,4,56,TWrex-cause,810676-FS1,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION)
725540296,5/25/2015 15:19:40,1643031590,5/25/2015 15:19:12,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],spontaneously,n/a,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:23:53,1643032939,5/25/2015 15:22:47,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],MACROSCOPIC HEMATURIA MICROSCOPIC HEMATURIA,same word,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:26:49,1643033753,5/25/2015 15:26:34,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[MANIFESTATION],[MANIFESTATION],often occurs,n/a,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:30:02,1643034710,5/25/2015 15:29:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],MACROSCOPIC HEMATURIA and MICROSCOPIC HEMATURIA,na,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:30:18,1643034771,5/25/2015 15:30:05,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],spontaneously,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:32:49,1643035579,5/25/2015 15:32:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],MACROSCOPIC HEMATURIA usually resolves spontaneously and MICROSCOPIC HEMATURIA often occurs between mucosal infections.,n/a,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:34:25,1643036041,5/25/2015 15:34:05,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],usually resolves,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:34:32,1643036081,5/25/2015 15:33:01,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],usually resolves,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:34:39,1643036124,5/25/2015 15:34:22,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[CAUSES] [CONTRAINDICATES] [IS_A] [NONE],"[CAUSES]
[CONTRAINDICATES]
[IS_A]
[NONE]",N/A,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:36:48,1643036795,5/25/2015 15:35:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:37:38,1643036982,5/25/2015 15:37:02,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[OTHER],[OTHER],and,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:38:53,1643037331,5/25/2015 15:38:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],between,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:39:58,1643037624,5/25/2015 15:39:45,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],MICROSCOPIC HEMATURIA,N/A,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:42:03,1643038441,5/25/2015 15:40:53,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],often occurs between mucosal infections.,n/a,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540296,5/25/2015 15:42:16,1643038535,5/25/2015 15:40:30,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],"usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA between mucosal infections.",n/a,0,70,1,20,91,TWrex-cause,814758-FS1,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA
725540297,5/25/2015 15:50:35,1643041125,5/25/2015 15:50:21,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[SYMPTOM] [PART_OF] [IS_A] [NONE],"[SYMPTOM]
[IS_A]
[PART_OF]
[NONE]",N/A,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 15:53:22,1643041802,5/25/2015 15:53:06,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],manifestations,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 15:55:14,1643042199,5/25/2015 15:54:17,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CROHN DISEASE,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 15:55:33,1643042221,5/25/2015 15:55:11,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[MANIFESTATION],[MANIFESTATION],Other manifestations,n/a,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 15:55:47,1643042254,5/25/2015 15:55:02,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[MANIFESTATION],[MANIFESTATION],manifestations include,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 15:57:59,1643042720,5/25/2015 15:57:30,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[SYMPTOM],[SYMPTOM],manifestations CROHN DISEASE inguinal ANAL FISTULAS,NONE,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:06:31,1643044451,5/25/2015 16:06:10,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[MANIFESTATION],[MANIFESTATION],Other manifestations of,n/a,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:06:34,1643044459,5/25/2015 16:05:55,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[MANIFESTATION],[MANIFESTATION],Other manifestations of CROHN DISEASE include ANAL FISTULAS,n/a,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:07:50,1643044770,5/25/2015 16:07:38,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[MANIFESTATION],[MANIFESTATION],manifestations,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:08:14,1643044887,5/25/2015 16:08:01,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[LOCATION] [NONE] [PART_OF] [IS_A] [ASSOCIATED_WITH],"[LOCATION]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]
[NONE]",N/A,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:09:28,1643045169,5/25/2015 16:09:07,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],Other manifestations of,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:13:22,1643046389,5/25/2015 16:12:51,false,clixsense,1.0,30544555,USA,TX,Mount Pleasant,70.196.7.174,[SYMPTOM],[SYMPTOM],CROHN DISEASE include ANAL FISTULAS,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:14:10,1643046622,5/25/2015 16:13:47,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],manifestations,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:14:29,1643046779,5/25/2015 16:13:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,n/a,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540297,5/25/2015 16:14:41,1643046854,5/25/2015 16:13:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],manifestations of,N/A,81,24,1,93,37,TWrex-cause,814914-FS1,Other manifestations of CROHN DISEASE include inguinal abscesses and sinuses and ANAL FISTULAS,ANAL FISTULAS,CROHN DISEASE
725540298,5/25/2015 16:20:45,1643048313,5/25/2015 16:20:31,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],symptoms,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 16:29:05,1643050160,5/25/2015 16:28:52,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],symptoms,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 16:43:38,1643053454,5/25/2015 16:42:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",n/a,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 16:44:09,1643053589,5/25/2015 16:43:53,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[LOCATION] [SIDE_EFFECT] [OTHER] [NONE],"[LOCATION]
[SIDE_EFFECT]
[OTHER]
[NONE]",N/A,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 16:47:11,1643054206,5/25/2015 16:46:31,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],signs indicative particularly,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 16:51:00,1643055289,5/25/2015 16:50:17,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],symptoms and signs indicative,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:02:39,1643059249,5/25/2015 17:02:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],particularly,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:05:16,1643060420,5/25/2015 17:04:00,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],symptoms particularly,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:06:27,1643060941,5/25/2015 17:06:00,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[SYMPTOM],[SYMPTOM],symptoms,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:07:38,1643061538,5/25/2015 17:07:05,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[IS_A],[IS_A],particularly,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:07:44,1643061600,5/25/2015 17:07:14,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[MANIFESTATION] [ASSOCIATED_WITH] [IS_A] [OTHER] [NONE],"[MANIFESTATION]
[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:07:58,1643061668,5/25/2015 17:07:36,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[SYMPTOM],[SYMPTOM],symptoms and signs,N/A,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:11:33,1643063462,5/25/2015 17:11:17,false,neodev,1,31789301,USA,CA,San Jose,23.27.248.31,[NONE],[NONE],no,no,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:14:03,1643064622,5/25/2015 17:12:26,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],particularly,n/a,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540298,5/25/2015 17:15:08,1643065156,5/25/2015 17:14:16,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[IS_A],[IS_A],particularly,n/a,124,97,1,134,110,TWrex-cause,813030-FS1,"C]  History and Physical Examination  3.1 Use history to elicit symptoms and signs indicative of ENDOMETRIOSIS particularly PELVIC PAIN a complex adnexal mass, or infertility.",PELVIC PAIN,ENDOMETRIOSIS
725540299,5/25/2015 15:22:39,1643032531,5/25/2015 15:22:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for the treatment of,n/a,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:30:57,1643034991,5/25/2015 15:30:32,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],FLUTICASONE PROPIONATE AEROSOL for treatment MILD TO MODERATE ASTHMA,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:32:51,1643035580,5/25/2015 15:32:39,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:35:46,1643036488,5/25/2015 15:35:19,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FLUTICASONE PROPIONATE AEROSOL for treatment of MILD TO MODERATE ASTHMA,na,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:37:00,1643036819,5/25/2015 15:36:49,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],FLUTICASONE PROPIONATE AEROSOL for the treatment of MODERATE ASTHMA,n/a,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:38:20,1643037172,5/25/2015 15:37:35,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [LOCATION] [ASSOCIATED_WITH] [NONE],"[PREVENTS]
[LOCATION]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:39:00,1643037366,5/25/2015 15:38:39,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:41:04,1643038035,5/25/2015 15:40:54,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:41:47,1643038316,5/25/2015 15:41:36,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:43:07,1643038874,5/25/2015 15:42:32,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],treatment of,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:43:41,1643039041,5/25/2015 15:43:25,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[MANIFESTATION],[MANIFESTATION],MILD MODERATE ASTHMA,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:44:26,1643039307,5/25/2015 15:43:53,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],FLUTICASONE PROPIONATE AEROSOL treatment MILD MODERATE ASTHMA,NONE,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:44:34,1643039323,5/25/2015 15:44:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],FLUTICASONE,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:44:35,1643039325,5/25/2015 15:44:13,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for the treatment of,n/a,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540299,5/25/2015 15:44:34,1643039326,5/25/2015 15:43:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,64,0,-1,86,30,TWrex-cause,803472-FS1,FLUTICASONE PROPIONATE AEROSOL for the treatment of adults with MILD TO MODERATE ASTHMA,MILD TO MODERATE ASTHMA,FLUTICASONE PROPIONATE AEROSOL
725540300,5/25/2015 15:17:50,1643031233,5/25/2015 15:17:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treated with,n/a,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:18:45,1643031429,5/25/2015 15:18:23,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],PAIN treated with ACETAMINOPHEN,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:25:11,1643033263,5/25/2015 15:24:57,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],with,n/a,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:25:33,1643033386,5/25/2015 15:24:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PAIN treated with ACETAMINOPHEN,na,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:27:58,1643034024,5/25/2015 15:27:26,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],treated with,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:28:25,1643034149,5/25/2015 15:28:07,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treated,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:29:39,1643034546,5/25/2015 15:28:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:29:59,1643034698,5/25/2015 15:29:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],PAIN without inflammation is with ACETAMINOPHEN,n/a,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:31:40,1643035246,5/25/2015 15:31:18,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:32:49,1643035577,5/25/2015 15:32:35,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [CONTRAINDICATES] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:34:17,1643035982,5/25/2015 15:34:09,false,cointasker,1,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treated,-,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:34:31,1643036062,5/25/2015 15:34:13,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treated,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:36:51,1643036792,5/25/2015 15:36:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treated,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:37:44,1643037004,5/25/2015 15:37:22,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],PAIN ACETAMINOPHEN,N/A,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540300,5/25/2015 15:38:03,1643037090,5/25/2015 15:37:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treated with,n/a,0,62,-1,3,75,TWrex-cause,804167-FS1,PAIN without inflammation is usually more safely treated with ACETAMINOPHEN,PAIN,ACETAMINOPHEN
725540301,5/25/2015 15:17:16,1643031121,5/25/2015 15:16:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for pelvic pain,n/a,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:17:31,1643031153,5/25/2015 15:16:36,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],endometriosis DANAZOL,Its one word,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:23:32,1643032848,5/25/2015 15:23:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],DANAZOL for pelvic pain associated with ENDOMETRIOSIS,na,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:24:20,1643033046,5/25/2015 15:23:58,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:26:42,1643033680,5/25/2015 15:26:06,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:27:26,1643033935,5/25/2015 15:26:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for pelvic pain associated with endometriosis,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:27:47,1643034001,5/25/2015 15:27:35,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],suppression,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:29:20,1643034417,5/25/2015 15:28:48,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],DANAZOL for pelvic pain associated with endometriosis,n/a,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:30:52,1643034985,5/25/2015 15:30:05,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:32:18,1643035411,5/25/2015 15:32:06,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[PREVENTS] [MANIFESTATION] [CONTRAINDICATES] [NONE],"[PREVENTS]
[MANIFESTATION]
[CONTRAINDICATES]
[NONE]",N/A,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:33:38,1643035791,5/25/2015 15:32:46,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],for,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:33:51,1643035852,5/25/2015 15:33:36,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,-,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:36:21,1643036670,5/25/2015 15:36:09,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],suppression,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:36:51,1643036793,5/25/2015 15:36:27,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[PREVENTS],[PREVENTS],DANAZOL ENDOMETRIOSIS,N/A,257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540301,5/25/2015 15:37:54,1643037038,5/25/2015 15:36:26,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"I don't understand the sentence, as far as I can tell, they are two unrelated locations, or illnesses",257,59,-1,269,66,TWrex-cause,803874-FS1,Cochrane Library  Ovulation suppression for endometriosis  DANAZOL for pelvic pain associated with endometriosis  Gonadotrophin releasing hormone analogues for pain associated with endometriosis  Modern combined oral contraceptives for pain associated with ENDOMETRIOSIS  Laparoscopic surgery for pelvic pain associated with endometriosis  Progestagens and anti progestagens for pain associated with endometriosis  Interventions for treating chronic pelvic pain in women.,ENDOMETRIOSIS,DANAZOL
725540302,5/25/2015 15:51:09,1643041222,5/25/2015 15:50:55,false,elite,1.0,31527522,USA,CA,Los Angeles,72.26.111.155,[CAUSES] [CONTRAINDICATES] [NONE],"[CAUSES]
[CONTRAINDICATES]
[NONE]",N/A,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 15:53:37,1643041850,5/25/2015 15:53:26,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],prevent,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 15:56:16,1643042314,5/25/2015 15:55:51,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],could produce increased pressure,n/a,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 15:56:24,1643042354,5/25/2015 15:55:59,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",to use to prevent,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 15:57:06,1643042537,5/25/2015 15:55:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],METOCLOPRAMIDE,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 15:58:29,1643042863,5/25/2015 15:58:01,false,neodev,1.0,31743852,GBR,G5,Margate,85.210.126.147,[TREATS],[TREATS],POSTOPERATIVE NAUSEA AND VOMITING possibility that METOCLOPRAMIDE produce increased pressure suture lines,NONE,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:07:34,1643044714,5/25/2015 16:06:35,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",POSTOPERATIVE NAUSEA AND VOMITING consider possibility METOCLOPRAMIDE could produce,n/a,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:08:06,1643044811,5/25/2015 16:07:54,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[PREVENTS],[PREVENTS],prevent,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:08:28,1643044938,5/25/2015 16:08:16,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[SYMPTOM] [MANIFESTATION] [NONE],"[SYMPTOM]
[MANIFESTATION]
[NONE]",N/A,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:09:48,1643045257,5/25/2015 16:09:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],to prevent,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:14:14,1643046653,5/25/2015 16:13:24,false,clixsense,1.0,30544555,USA,TX,Mount Pleasant,70.196.7.174,[MANIFESTATION],[MANIFESTATION],POSTOPERATIVE VOMITING possibility METOCLOPRAMIDE,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:14:39,1643046811,5/25/2015 16:14:27,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[MANIFESTATION],[MANIFESTATION],metoclopramide,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:15:21,1643046937,5/25/2015 16:13:49,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],to prevent POSTOPERATIVE NAUSEA AND VOMITING,N/A,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:16:00,1643047070,5/25/2015 16:14:30,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],General Precautions GI Anastomosis or Closure When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.,n/a,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540302,5/25/2015 16:16:11,1643047119,5/25/2015 16:14:41,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],increased pressure on suture lines,seems to affect something else but not directly related to vomitting,128,192,-1,160,206,TWrex-cause,804325-FS1,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE
725540303,5/25/2015 15:12:45,1643030128,5/25/2015 15:11:32,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[MANIFESTATION],[MANIFESTATION],TPALLIDUM presumed to replicate SECONDARY SYPHILIS,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:15:16,1643030746,5/25/2015 15:14:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:21:08,1643032034,5/25/2015 15:20:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],TPALLIDUM in patients with SECONDARY SYPHILIS,na,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:21:36,1643032144,5/25/2015 15:20:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",course of therapy.,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:22:10,1643032308,5/25/2015 15:20:47,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[MANIFESTATION],[MANIFESTATION],presumed to replicate relatively short,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:22:30,1643032455,5/25/2015 15:22:13,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,http://www.expedia.com/Abu-Dhabi-Emirate-Hotels-Howard-Johnson-Hotel-Diplomat-Abu-Dhabi-AE.h533280.Hotel-Information,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:26:32,1643033637,5/25/2015 15:26:08,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy.,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:27:16,1643033881,5/25/2015 15:26:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SIDE_EFFECT],[SIDE_EFFECT],TPALLIDUM in patients and SECONDARY SYPHILIS,n/a,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:28:09,1643034059,5/25/2015 15:27:47,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:30:24,1643034800,5/25/2015 15:28:39,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],in patients with,n/a,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:30:49,1643034966,5/25/2015 15:29:40,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is presumed to replicate,n/a,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:30:49,1643034967,5/25/2015 15:29:36,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],in,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:30:53,1643034988,5/25/2015 15:30:39,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[CAUSES] [TREATS] [NONE],"[TREATS]
[CAUSES]
[NONE]",N/A,N/A,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:31:40,1643035249,5/25/2015 15:31:20,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],presumed,-,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540303,5/25/2015 15:32:14,1643035391,5/25/2015 15:31:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presumed to replicate,n/a,125,16,1,142,24,TWrex-cause,812466-FS1,"Rationale: •   TPALLIDUM  in patients with early latent syphilis is presumed to replicate at rates approximating primary and SECONDARY SYPHILIS and therefore, like those early stages of syphilis, requires a relatively short course of therapy.",SECONDARY SYPHILIS,PALLIDUM
725540304,5/25/2015 16:19:58,1643048119,5/25/2015 16:19:46,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:28:24,1643050061,5/25/2015 16:28:12,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:39:22,1643052320,5/25/2015 16:39:06,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[MANIFESTATION],[MANIFESTATION],initial presentation of,N/a,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:40:37,1643052592,5/25/2015 16:39:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],DKA may be the initial presentation of DIABETES MELLITUS,n/a,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:40:56,1643052701,5/25/2015 16:40:02,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[SYMPTOM],[SYMPTOM],initial presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:43:17,1643053341,5/25/2015 16:43:06,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[SYMPTOM] [ASSOCIATED_WITH] [IS_A] [OTHER] [NONE],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:48:31,1643054502,5/25/2015 16:47:31,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[SYMPTOM],[SYMPTOM],initial presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 16:52:42,1643055725,5/25/2015 16:52:23,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],DKA may be the initial presentation of DIABETES MELLITUS,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:01:01,1643058516,5/25/2015 17:00:24,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],initial presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:01:01,1643058535,5/25/2015 17:00:48,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:04:22,1643059994,5/25/2015 17:03:35,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[MANIFESTATION],[MANIFESTATION],initial presentation,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:06:04,1643060739,5/25/2015 17:05:39,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",initial presentation of,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:06:30,1643060964,5/25/2015 17:06:15,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[CAUSES] [CONTRAINDICATES] [OTHER] [NONE],"[CAUSES]
[CONTRAINDICATES]
[OTHER]
[NONE]",N/A,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:06:39,1643061052,5/25/2015 17:06:11,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[SYMPTOM],[SYMPTOM],may be the initial presentation of,N/A,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540304,5/25/2015 17:08:56,1643062158,5/25/2015 17:08:22,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[SYMPTOM],[SYMPTOM],presentation,n/a,0,51,1,3,68,TWrex-cause,814887-FS1,DKA may be the initial presentation of DIABETES MELLITUS,DKA,DIABETES MELLITUS
725540305,5/25/2015 16:12:48,1643046148,5/25/2015 16:12:32,false,elite,1.0,31227441,USA,AZ,Tempe,23.235.227.106,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:16:50,1643047306,5/25/2015 16:16:37,false,elite,1.0,31528450,USA,CA,Napa,38.110.180.195,[ASSOCIATED_WITH] [PART_OF] [NONE],"[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:18:31,1643047860,5/25/2015 16:18:17,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"detected,",N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:26:49,1643049675,5/25/2015 16:26:38,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],"detected,",N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:30:40,1643050529,5/25/2015 16:30:02,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:32:49,1643051049,5/25/2015 16:31:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CONTRAINDICATES],[CONTRAINDICATES],"If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",n/a,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:36:19,1643051507,5/25/2015 16:35:41,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:37:09,1643051722,5/25/2015 16:36:45,false,prodege,1.0,22031444,GBR,M4,Southampton,2.98.199.6,[NONE],[NONE],N/A,Unrelated terms,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:40:55,1643052697,5/25/2015 16:40:19,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[CAUSES] [ASSOCIATED_WITH] [NONE],"[CAUSES]
[ASSOCIATED_WITH]
[NONE]",N/A,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:41:40,1643052918,5/25/2015 16:41:05,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[OTHER],[OTHER],discontinue,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:50:09,1643054963,5/25/2015 16:49:59,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CONTRAINDICATES],[CONTRAINDICATES],"If PREGNANCY is detected, discontinue TRANDOLAPRIL",N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:55:28,1643056522,5/25/2015 16:54:12,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,n/a,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:56:47,1643056982,5/25/2015 16:56:06,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CONTRAINDICATES],[CONTRAINDICATES],discontinue as soon as possible.,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:57:10,1643057075,5/25/2015 16:56:18,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],discontinue,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540305,5/25/2015 16:58:58,1643057694,5/25/2015 16:58:26,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,N/A,6,41,-1,14,53,TWrex-cause,803118-FS1,"•  If PREGNANCY is detected, discontinue TRANDOLAPRIL as soon as possible.",PREGNANCY,TRANDOLAPRIL
725540306,5/25/2015 15:16:35,1643031001,5/25/2015 15:15:53,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],PAIN with REFRACTORY TRIGEMINAL NEURALGIA,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:16:47,1643031019,5/25/2015 15:16:32,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],relieved,n/a,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:23:04,1643032683,5/25/2015 15:22:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],patients with MS and REFRACTORY TRIGEMINAL NEURALGIA,na,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:23:57,1643032962,5/25/2015 15:23:41,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],with,n/a,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:25:55,1643033449,5/25/2015 15:25:18,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[TREATS],[TREATS],relieved PAIN,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:26:15,1643033541,5/25/2015 15:25:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],in patients with,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:27:33,1643033967,5/25/2015 15:27:19,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Gabapentin,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:28:47,1643034209,5/25/2015 15:28:27,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Gabapentin relieved PAIN in six of seven patients with REFRACTORY TRIGEMINAL NEURALGIA,n/a,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:30:03,1643034713,5/25/2015 15:29:39,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],relieved,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:32:04,1643035355,5/25/2015 15:31:41,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[TREATS] [LOCATION] [SYMPTOM] [CAUSES] [NONE],"[TREATS]
[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",N/A,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:32:44,1643035573,5/25/2015 15:32:14,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],in,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:33:29,1643035766,5/25/2015 15:33:12,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],with,-,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:36:04,1643036560,5/25/2015 15:35:48,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],Gabapentin,N/A,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:36:14,1643036626,5/25/2015 15:34:05,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],in patients with,n/a,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540306,5/25/2015 15:38:36,1643037278,5/25/2015 15:38:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],relieved with,n/a,32,85,1,35,116,TWrex-cause,814889-FS1,Evidence: • Gabapentin relieved PAIN completely in six of seven patients with MS and REFRACTORY TRIGEMINAL NEURALGIA and significantly in the seventh patient ( 87.,PAIN,REFRACTORY TRIGEMINAL NEURALGIA
725540307,5/25/2015 15:20:51,1643031971,5/25/2015 15:20:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Effect of,n/a,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:26:50,1643033750,5/25/2015 15:26:20,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],Effect of PROPRANOLOL on ESSENTIAL TREMOR,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:27:51,1643034006,5/25/2015 15:27:36,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Effect of,n/a,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:31:21,1643035119,5/25/2015 15:31:08,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],Effect,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:31:54,1643035341,5/25/2015 15:31:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Effect of PROPRANOLOL on ESSENTIAL TREMOR,na,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:34:36,1643036114,5/25/2015 15:34:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Effect of PROPRANOLOL on ESSENTIAL TREMOR,n/a,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:35:40,1643036447,5/25/2015 15:35:26,false,elite,1.0,31536964,USA,CA,Berkeley,67.180.156.186,[TREATS] [SYMPTOM] [ASSOCIATED_WITH] [IS_A] [NONE],"[TREATS]
[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[NONE]",N/A,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:36:07,1643036580,5/25/2015 15:35:39,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:37:33,1643036962,5/25/2015 15:37:03,false,points4rewards,1.0,28703583,USA,"","",97.73.93.107,[MANIFESTATION],[MANIFESTATION],Effect of,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:38:59,1643037350,5/25/2015 15:38:44,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],Effect,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:40:04,1643037675,5/25/2015 15:39:50,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CONTRAINDICATES],[CONTRAINDICATES],Effect,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:40:54,1643037970,5/25/2015 15:40:20,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Effect of PROPRANOLOL on,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:41:20,1643038141,5/25/2015 15:41:00,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[IS_A],[IS_A],Fogelholm PROPRANOLOL ESSENTIAL TREMOR,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:42:37,1643038685,5/25/2015 15:42:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ESSENTIAL TREMOR,N/A,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540307,5/25/2015 15:42:39,1643038691,5/25/2015 15:42:06,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],Effect of on,n/a,62,47,-1,77,58,TWrex-cause,804967-FS1,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL
725540308,5/25/2015 16:48:46,1643054538,5/25/2015 16:48:15,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[NONE] [PART_OF] [IS_A] [OTHER],"[IS_A]
[PART_OF]
[OTHER]
[NONE]",N/A,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:01:44,1643058838,5/25/2015 17:00:52,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[TREATS],[TREATS],reduced when used to achieve tight control,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:12:03,1643063654,5/25/2015 17:11:49,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[MANIFESTATION] [ASSOCIATED_WITH] [PART_OF] [NONE],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]
[NONE]",N/A,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:13:18,1643064289,5/25/2015 17:12:55,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS] [PREVENTS] [MANIFESTATION],"[TREATS]
[PREVENTS]
[MANIFESTATION]",reduced episodes in,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:13:32,1643064421,5/25/2015 17:13:12,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[TREATS],[TREATS],reduced,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:14:00,1643064610,5/25/2015 17:13:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],used to achieve tight glycemic control,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:17:09,1643066140,5/25/2015 17:16:19,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[TREATS],[TREATS],reduced,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:25:58,1643070435,5/25/2015 17:25:46,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[LOCATION] [IS_A] [PART_OF] [NONE],"[LOCATION]
[IS_A]
[PART_OF]
[NONE]",N/A,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:28:11,1643071433,5/25/2015 17:27:24,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced nocturnal hypoglycemic episodes in,n/a,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:28:42,1643071635,5/25/2015 17:28:11,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],reduced,n/a,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:32:31,1643073186,5/25/2015 17:31:46,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS,n/a,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:34:30,1643074306,5/25/2015 17:33:57,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[OTHER],[OTHER],reduced,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:34:56,1643074503,5/25/2015 17:34:20,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],reduced,N/A,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:35:25,1643074726,5/25/2015 17:34:59,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[TREATS],[TREATS],reduced,n/a,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540308,5/25/2015 17:38:31,1643076318,5/25/2015 17:38:02,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],hypoglycemic,n/a,58,8,-1,81,14,TWrex-cause,800006-FS1,"Insulin LISPRO reduced nocturnal hypoglycemic episodes in TYPE 1 DIABETES MELLITUS when used to achieve tight glycemic control  Keywords: Blood glucose Diabetes mellitus, insulin dependent Hypoglycemia Hypoglycemic agents Insulin.",TYPE 1 DIABETES MELLITUS,LISPRO
725540309,5/25/2015 16:31:35,1643050740,5/25/2015 16:31:09,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],cause,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 16:47:58,1643054329,5/25/2015 16:47:47,false,elite,1.0,31526431,USA,CA,Elk Grove,67.166.135.122,[SYMPTOM] [CONTRAINDICATES] [IS_A] [OTHER] [NONE],"[SYMPTOM]
[CONTRAINDICATES]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 16:59:56,1643058052,5/25/2015 16:59:26,false,meprizescf,1.0,31395940,USA,NY,Victor,72.230.179.20,[LOCATION],[LOCATION],clinically uninvolved SKIN of,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:08:09,1643061789,5/25/2015 17:07:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],of patients with,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:11:28,1643063413,5/25/2015 17:10:59,false,elite,1.0,31868941,USA,CO,Englewood,63.228.91.212,[IS_A] [OTHER] [NONE],"[IS_A]
[OTHER]
[NONE]",N/A,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:12:18,1643063776,5/25/2015 17:11:50,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",of patients with,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:12:39,1643064032,5/25/2015 17:11:54,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],SKIN,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:12:41,1643064037,5/25/2015 17:12:21,false,neodev,1.0,14861092,GBR,C1,Bury,90.212.46.98,[LOCATION],[LOCATION],of patients with,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:15:38,1643065432,5/25/2015 17:14:22,false,prodege,1.0,19854505,GBR,H8,Liverpool,92.28.85.177,[LOCATION],[LOCATION],SKIN with,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:25:24,1643070130,5/25/2015 17:25:09,false,elite,1.0,31869729,USA,CO,Pueblo,67.190.156.46,[CAUSES] [CONTRAINDICATES] [IS_A] [OTHER] [NONE],"[CAUSES]
[CONTRAINDICATES]
[IS_A]
[OTHER]
[NONE]",N/A,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:26:32,1643070703,5/25/2015 17:26:14,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],patients with,n/a,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:27:11,1643070977,5/25/2015 17:26:29,false,elite,1.0,28624269,USA,NY,New York,198.199.80.197,[MANIFESTATION],[MANIFESTATION],cause,n/a,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:30:42,1643072421,5/25/2015 17:29:10,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[ASSOCIATED_WITH],[ASSOCIATED_WITH],uninvolved SKIN of patients with PSORIASIS,n/a,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:33:10,1643073487,5/25/2015 17:32:18,false,clixsense,1.0,31345986,GBR,X4,Nelson,86.142.70.187,[LOCATION],[LOCATION],of patients with,N/A,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
725540309,5/25/2015 17:34:15,1643074121,5/25/2015 17:33:11,false,bitcoinget,1.0,24960279,USA,NY,Bronx,69.112.194.17,[CAUSES],[CAUSES],cause lesion,n/a,51,73,-1,54,82,TWrex-cause,802702-FS1,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS
